<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><?covid-19-tdm ?><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">86015</article-id><article-id pub-id-type="doi">10.7554/eLife.86015</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Viral persistence, reactivation, and mechanisms of long COVID</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-184509"><name><surname>Chen</surname><given-names>Benjamin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5404-1997</contrib-id><email>benjamin.chen@mssm.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-204941"><name><surname>Julg</surname><given-names>Boris</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4687-9626</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-302838"><name><surname>Mohandas</surname><given-names>Sindhu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8397-6249</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-200552"><name><surname>Bradfute</surname><given-names>Steven B</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1985-751X</contrib-id><email>sbradfute@salud.unm.edu</email><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><collab>RECOVER Mechanistic Pathways Task Force<contrib-group><contrib><name><surname>Sherif</surname><given-names>Zaki A</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05gt1vc06</institution-id><institution>Department of Biochemistry &amp; Molecular Biology, Howard University College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Washington</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Gomez</surname><given-names>Christian R</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>Division of Lung Diseases, National Institutes of Health (NIH), National Heart Lung and Blood Institute (NHLBI)</institution></institution-wrap><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Connors</surname><given-names>Thomas J</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/016m8pd54</institution-id><institution>Department of Pediatrics, Division of Critical Care, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Henrich</surname><given-names>Timothy J</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Division of Experimental Medicine, University of California, San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Reeves</surname><given-names>W Brian</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01kd65564</institution-id><institution>Department of Medicine, Joe R. and Teresa Lozano Long School of Medicine, University of Texas</institution></institution-wrap><addr-line><named-content content-type="city">San Antonio</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Coombs</surname><given-names>K</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>NIH RECOVER Research Initiative: Patient representative</institution></institution-wrap><addr-line><named-content content-type="city">Bronx</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Kim</surname><given-names>C</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>NIH RECOVER Research Initiative: Patient representative</institution></institution-wrap><addr-line><named-content content-type="city">Bronx</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Jagannathan</surname><given-names>Pras</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University</institution></institution-wrap><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Bime</surname><given-names>Christian</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03m2x1q45</institution-id><institution>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, University of Arizona College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Tucson</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Quinlan</surname><given-names>Erin Burke</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00190t495</institution-id><institution>National Center for Complementary and Integrative Health, National Institutes of Health</institution></institution-wrap><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Portman</surname><given-names>Michael A</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cvxb145</institution-id><institution>Seattle Children’s Hospital, Division of Pediatric Cardiology, Department of Pediatrics, University of Washington</institution></institution-wrap><addr-line><named-content content-type="city">Seattle</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Gennaro</surname><given-names>Maria Laura</given-names></name><aff><institution>Public Health Research Institute and Department of Medicine, Rutgers New Jersey Medical School</institution><addr-line><named-content content-type="city">Newark</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Rehman</surname><given-names>Jalees</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02mpq6x41</institution-id><institution>Department of Biochemistry and Molecular Genetics, University of Illinois, College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></collab><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/002pd6e78</institution-id><institution>Infectious Diseases Division, Massachusetts General Hospital, Ragon Institute of Mass General, MIT and Harvard</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03taz7m60</institution-id><institution>Division of Infectious Diseases, Department of Pediatrics, Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern California</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05fs6jp91</institution-id><institution>Center for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center</institution></institution-wrap><addr-line><named-content content-type="city">Albuquerque</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Iqbal</surname><given-names>Jameel</given-names></name><role>Reviewing Editor</role><aff><institution>DaVita Labs</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>04</day><month>05</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e86015</elocation-id><history><date date-type="received" iso-8601-date="2023-01-09"><day>09</day><month>01</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-04-24"><day>24</day><month>04</month><year>2023</year></date></history><permissions><ali:free_to_read/><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><ali:license_ref>http://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0 public domain dedication</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-86015-v1.pdf"/><related-article related-article-type="article-reference" ext-link-type="doi" xlink:href="10.7554/eLife.86002" id="ra1"/><related-article related-article-type="article-reference" ext-link-type="doi" xlink:href="10.7554/eLife.86014" id="ra2"/><related-article related-article-type="article-reference" ext-link-type="doi" xlink:href="10.7554/eLife.86043" id="ra3"/><abstract><p>The COVID-19 global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has infected hundreds of millions of individuals. Following COVID-19 infection, a subset can develop a wide range of chronic symptoms affecting diverse organ systems referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), also known as long COVID. A National Institutes of Health-sponsored initiative, RECOVER: Researching COVID to Enhance Recovery, has sought to understand the basis of long COVID in a large cohort. Given the range of symptoms that occur in long COVID, the mechanisms that may underlie these diverse symptoms may also be diverse. In this review, we focus on the emerging literature supporting the role(s) that viral persistence or reactivation of viruses may play in PASC. Persistence of SARS-CoV-2 RNA or antigens is reported in some organs, yet the mechanism by which they do so and how they may be associated with pathogenic immune responses is unclear. Understanding the mechanisms of persistence of RNA, antigen or other reactivated viruses and how they may relate to specific inflammatory responses that drive symptoms of PASC may provide a rationale for treatment.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>SARS-CoV-2</kwd><kwd>long COVID</kwd><kwd>viral persistence</kwd><kwd>Reactivation</kwd><kwd>PASC</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>OT2HL161847 (contract number 01)</award-id><principal-award-recipient><name><surname>Bradfute</surname><given-names>Steven B</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Persistence of severe acute respiratory syndrome coronavirus 2 and reactivation of unrelated latent viruses may play a role in the development and pathogenesis of long COVID, and future research should focus on identifying the mechanisms behind these interactions.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The Mechanistic Pathways task force within the National Institutes of Health Researching COVID to Enhance Recovery (RECOVER) consortium seeks a mechanistic understanding of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), also known as ‘long COVID,’ to guide treatments. In a majority of individuals infected with SARS-CoV-2, live virus is fully cleared within days to a few weeks after infection and no longer detectable in the respiratory system. However, resolution of viral RNA or antigen from the respiratory epithelia or other tissue sites can be slow, and in some cases viruses may persist in forms that are not well understood. Fundamental questions regarding the relationship between persistence of SARS-CoV-2 and longevity of symptoms of PASC are unresolved. SARS-CoV-2 infection can result in long-term symptoms even if the infection is mild or asymptomatic. There is a wide range of PASC symptoms that can affect different organ systems, including cardiac, respiratory, and neurological processes. Most clinical monitoring of the virus has been conducted in the respiratory tract, although other compartments have been found to harbor SARS-CoV-2. Interestingly, inflammatory responses to SARS-CoV-2 infection can co-exist with re-activation of herpesvirus infections, such as Epstein–Barr virus (EBV). In particular, EBV has been suggested to be associated with chronic fatigue, brain fog, or other symptoms that may resemble PASC symptoms. In fact, infection with other viral or bacterial pathogens has been linked to the development of chronic symptoms in a subset of infected individuals (<xref ref-type="bibr" rid="bib7">Bannister, 1988</xref>; <xref ref-type="bibr" rid="bib43">Keita et al., 2019</xref>; <xref ref-type="bibr" rid="bib46">Komaroff, 2006</xref>; <xref ref-type="bibr" rid="bib66">Rebman and Aucott, 2020</xref>; <xref ref-type="bibr" rid="bib88">Wilson et al., 2018</xref>; <xref ref-type="bibr" rid="bib94">Zaid et al., 2018</xref>). Viral persistence in so-called ‘sanctuary tissues’ has been demonstrated for Ebola virus (<xref ref-type="bibr" rid="bib43">Keita et al., 2019</xref>; <xref ref-type="bibr" rid="bib53">Lo et al., 2017</xref>), even after the virus has cleared from blood, persisting for months to years and in some cases inducing chronic symptoms or reactivation of live Ebola virus that results in new outbreaks (<xref ref-type="bibr" rid="bib18">Clark et al., 2015</xref>; <xref ref-type="bibr" rid="bib44">Keita et al., 2021</xref>; <xref ref-type="bibr" rid="bib88">Wilson et al., 2018</xref>). It is still unclear whether SARS-CoV-2 persistence and latent pathogen reactivation plays a role in PASC, and if so, what mechanisms are involved.</p><p>The subcommittee identified two priority areas of research with several subtopics (see <xref ref-type="fig" rid="fig1">Figure 1</xref>) that may help determine whether treatment of PASC should employ vaccines or drugs that target SARS-CoV-2 or other reactivated pathogens.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Summary of potential viral, immune, and tissue roles in post-acute sequelae of SARS CoV-2 infection (PASC).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86015-fig1-v1.tif"/></fig></sec><sec id="s2"><title>SARS-CoV-2 viral persistence</title><sec id="s2-1"><title>Tissue tropism</title><p>SARS-CoV-2 primarily infects individuals through the respiratory epithelium by entering cells that carry the ACE-2 receptor and TMPRSS2 coreceptor in the nasal or upper respiratory epithelium (<xref ref-type="bibr" rid="bib19">Clausen et al., 2020</xref>; <xref ref-type="bibr" rid="bib39">Hoffmann et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Melms et al., 2021</xref>; <xref ref-type="bibr" rid="bib73">Shang et al., 2020</xref>; <xref ref-type="bibr" rid="bib78">Sungnak et al., 2020</xref>; <xref ref-type="bibr" rid="bib92">Yan et al., 2020</xref>). Diverse cell types within different organ systems express receptors that may make these cells directly vulnerable to infection by SARS-CoV-2, including alveolar macrophages; renal tubular cells; gastrointestinal epithelia in the ileum, colon, and rectum; esophageal keratinocytes; and liver cholangiocytes (<xref ref-type="bibr" rid="bib26">Delorey et al., 2021</xref>; <xref ref-type="bibr" rid="bib36">Gupta et al., 2020</xref>; <xref ref-type="bibr" rid="bib64">Puelles et al., 2020</xref>; <xref ref-type="bibr" rid="bib65">Qi et al., 2020</xref>; <xref ref-type="bibr" rid="bib26">Delorey et al., 2021</xref>). Other cells including neurons in the brain are also observed to be infected and may express low levels of ACE-2 or may use alternative coreceptors (<xref ref-type="bibr" rid="bib76">Song et al., 2021</xref>). Autopsy studies in acute infection show infection of cells in the olfactory mucosal cells including some neurons and endothelial cells within the brain parenchyma (<xref ref-type="bibr" rid="bib55">Matschke et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Meinhardt et al., 2021</xref>). Other single-cell studies of SARS-CoV-2 in the brain reveal no molecular traces of virus in the brain, but they did detect inflammation in choroid plexus cells and find T cells infiltrating the brain (<xref ref-type="bibr" rid="bib93">Yang et al., 2021</xref>). The existence of diverse viral targets of infection can explain the symptoms of acute infection, though how the impact of acute infection leads to the prolonged symptoms associated with PASC is still uncertain.</p></sec><sec id="s2-2"><title>Characteristics of persistent SARS-CoV-2</title><p>SARS-CoV-2 RNA can persist for many weeks in the respiratory tract of individuals that have recovered clinically from COVID-19 (<xref ref-type="bibr" rid="bib12">Cevik et al., 2021</xref>), though the period during which one can isolate infectious virus is much more limited. The persistence of viral RNA in compartments has been primarily measured from the different compartments that shed virus or are easily accessible including the respiratory tract, gastrointestinal tract, and blood. An extensive meta-analysis by Cevik et al. indicates that shedding of virus (as detected by PCR) can continue for prolonged periods in a broad sampling of the population recovering from SARS-CoV-2 infection. The mean duration of shedding is 17 days in the upper respiratory tract, 14.6 days in the lower respiratory tract, 17.2 days in the gastrointestinal tract (fecal), and 16.6 days in blood. The maximum duration of viral RNA shedding was 83 days in the upper respiratory tract, 59 days in the lower respiratory tract, 126 days in stool samples, and 60 d in serum samples. The detection of RNA in the blood during the acute phase of COVID-19 has been correlated with risk of PASC, though in these patients, RNA is generally barely detectable after several months (<xref ref-type="bibr" rid="bib77">Su et al., 2022</xref>). This may indicate that broad seeding of different organ systems may lead to complications during the recovery. A major question regarding persistence of symptoms is whether the persistence of virus in different compartments may correlate with PASC symptoms. For instance, while there is evidence for infection of olfactory neurons, endothelial cells, and infiltration of immune cells in the CNS, the relationship of persistence of symptoms in the CNS and if they are driven by virus or antigens in the CNS or systemically is still unclear.</p><p>Little is known regarding the presence of SARS-CoV-2 viral particles when RNA for SARS-CoV-2 is detectable. Is persisting virus replicating or non-replicating? Most studies that address this issue have been designed to examine the infectiousness of individuals whose fluids test positive for viral RNA. The ability to culture virus from secretions generally is limited to the earlier phases of recovery (<xref ref-type="bibr" rid="bib9">Bullard et al., 2020</xref>; <xref ref-type="bibr" rid="bib52">Liu et al., 2020</xref>; <xref ref-type="bibr" rid="bib89">Wölfel et al., 2020</xref>), except in those with significant immune defects that may enable persistent infection. The ability to sample tissue sites may be different from respiratory, fecal, or blood-derived samples that are relatively simple to collect.</p><p>In peripheral blood monocytes, persistence of S1 antigen has been detected by antibody and mass spectrometry in 4 out of 11 severe COVID-19 patients and 1 out of 26 PASC patients, in some cases up to 15 months post infection. In this study, only fragmented RNA could be detected, suggesting that the antigen is not being expressed actively from these cells (<xref ref-type="bibr" rid="bib60">Patterson et al., 2021</xref>). Viral RNA has been detected in patients with persistent symptoms after COVID-19 in the blood, stool, and urine (<xref ref-type="bibr" rid="bib81">Tejerina et al., 2022</xref>). The detection of RNAemia and soluble spike antigen in peripheral blood has been associated with PASC in a small group of post-acute COVID patients (<xref ref-type="bibr" rid="bib22">Craddock et al., 2023</xref>; <xref ref-type="bibr" rid="bib21">Craddock et al., 2022</xref>). Using ultrasensitive ELISA 60% of individuals with PASC had detectable plasma Spike antigen (<xref ref-type="bibr" rid="bib79">Swank et al., 2023</xref>). Larger studies are needed to determine whether detection of antigen in these patients is associated with particular symptoms during PASC. In patients with long-lasting olfactory loss, viral RNA could be detected in cells obtained from cytobrush samples but not from routine swabs, and detection of N protein correlated with signs of local inflammation (<xref ref-type="bibr" rid="bib27">de Melo et al., 2021</xref>). An absence of subgenomic RNA was noted that may be indicative of a lack of active local replication.</p><p>Analysis of biopsies from the gastrointestinal tract by immunofluorescence against S and by PCR suggested that antigen persisted in the small bowel in 7 of 14 individuals who were asymptomatic at 4 months after the onset of coronavirus disease (<xref ref-type="bibr" rid="bib33">Gaebler et al., 2021</xref>). In patients with GI PASC, it has been described that new effector T cell responses may correlate with prolonged symptoms, perhaps indicating that an immune stimulus is still present (<xref ref-type="bibr" rid="bib77">Su et al., 2022</xref>). In these studies, the authors found persistence of RNA and antigen in 7/14 asymptomatic individuals at 4 months after the onset of COVID-19. Persistence of viral RNA in the gastrointestinal tract has also been found in 32 of 46 patients with inflammatory bowel disease, with viral nucleocapsid detected in 24 of 46. Viral antigens were not detectable in stool and live virus could not be cultured (<xref ref-type="bibr" rid="bib96">Zollner et al., 2022</xref>). Post-acute sequelae were reported in a majority of patients with antigen persistence but not from those without antigen persistence, leading the authors to conclude that viral antigen persistence forms a basis for post-acute COVID-19. The use of biopsies to assess the low-level persistence of RNA, protein, or active replication-competent virus is not easily performed on some tissues that may be involved in PASC such as the brain, lung, or gastrointestinal tract. Obtaining tissues from symptomatic PASC and asymptomatic patients would be enabled by RECOVER and could lead to a better understanding of the beneficial or pathogenic role(s) of this type of persistent antigen.</p><p>The typical half-life of mRNA in the cell is generally thought to be short lived, measured in minutes to hours rather than months or years, and there are not thought to be major exceptions for specific RNAs (<xref ref-type="bibr" rid="bib74">Sharova et al., 2009</xref>). Thus, the persistence of SARS-CoV-2 RNA is mechanistically a mystery. To date, there is no clear evidence of active viral replication in PASC, though an open question is whether there is persistent viral antigen inducing inflammatory responses within tissues, lungs, brain, and heart. If so, why are these cells that are expressing residual antigen not cleared? Is persistent spike-antigen presence triggering cross-reactive immune responses, similar to other post-infectious syndromes? It should be noted that highly sensitive and specific, reliable, quantifiable, and reproducible detection of viral antigens and/or viral nucleic acids is critical to answer these questions. This is true for SARS-CoV-2 but also for other potentially reactivating viruses (see sections below). Nucleic acid-based detection methods fulfill some of these criteria, but contamination can significantly affect the results. Antibody-based detection of antigens, that is, in tissues, in contrast might be more robust but does not typically achieve the same sensitivity and specificity as nucleic acid detection methods (<xref ref-type="bibr" rid="bib10">Cassedy et al., 2021</xref>). Spurious results therefore carry the risk for misinterpreting the causal relationship between virus persistence and PASC. Close collaboration between laboratories that study viral persistence and ideally coordinated assay qualification would help reduce and hopefully eliminate these risks. The RECOVER study therefore provides a unique opportunity for such an approach.</p></sec><sec id="s2-3"><title>Adaptive/innate immune responses</title><p>Repeated antigen exposure is a critical component for the induction of robust and durable adaptive immune responses. In fact, antigen-specific T and B cell populations usually contract once the inducing antigen is cleared. Ongoing evolution of antigen-specific immunity can therefore be evidence for chronic and/or latent infection or persistent antigen presence in the absence of active viral replication, resulting in chronic stimulation of adaptive immune responses. There is a comprehensive body of evidence suggesting that titers of IgM and IgG antibodies against the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 significantly decrease over time while SARS-CoV-2-specific CD4+ and CD8+ T cell response remain more stable (<xref ref-type="bibr" rid="bib8">Bilich et al., 2021</xref>; <xref ref-type="bibr" rid="bib40">Ibarrondo et al., 2020</xref>; <xref ref-type="bibr" rid="bib72">Seow et al., 2020</xref>; <xref ref-type="bibr" rid="bib91">Yamayoshi et al., 2021</xref>). In contrast, in a cohort of 87 individuals the frequency of RBD-specific memory B cells appeared to remain stable after SARS-CoV-2 infection and memory B cells displayed ongoing clonal turnover after ~6 months following infection, expressing antibodies with greater somatic hypermutation, indicative of continued evolution of the humoral response (<xref ref-type="bibr" rid="bib17">Cho et al., 2021</xref>). Furthermore, in a subset of this cohort, persistence of SARS-CoV-2 nucleic acids and immunoreactivity in the small bowel was observed, suggesting that humoral evolution might be linked to antigen persistence. For T-cell responses, in contrast, it has recently been reported that the T-cell receptor (TCR) repertoire diversity decreases quickly after recovering from COVID-19 without changing the global frequency of VDJ gene usage (<xref ref-type="bibr" rid="bib54">Luo et al., 2021</xref>). SARS-CoV-2-specific CD8+ T-cell responses of significantly increased breadth and magnitude, however, were observed in a small subset of individuals who remained positive for SARS-CoV-2 via RT-PCR nasopharyngeal testing up to 90 d following acute COVID-19, suggesting that such subjects might still harbor replicating virus that drives T-cell activation and evolution (<xref ref-type="bibr" rid="bib85">Vibholm et al., 2021</xref>). Moreover, cytotoxic CD8+, but also CD4+ T-cell populations, were significantly enriched in individuals with gastrointestinal PASC, suggesting ongoing replenishment and clonal expansion of these cell populations associated with long COVID (<xref ref-type="bibr" rid="bib77">Su et al., 2022</xref>). Therefore, an unresolved, overarching question is whether viral persistence correlates with evolution of antibody/T-cell responses or inflammatory innate immune responses in PASC.</p><p>Severe COVID-19 can result in decreased frequencies and functional exhaustion of antiviral cytotoxic lymphocytes, including cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells, as well as diminished frequencies of plasmacytoid dendritic cells (pDCs) (<xref ref-type="bibr" rid="bib28">Diao et al., 2020</xref>; <xref ref-type="bibr" rid="bib32">Files et al., 2021</xref>; <xref ref-type="bibr" rid="bib67">Ren et al., 2021</xref>; <xref ref-type="bibr" rid="bib95">Zheng et al., 2020</xref>). In fact, postmortem autopsies of individuals with COVID-19 found a general deficiency of T cells and B cells in lung infiltrates, while innate immune cells were enriched (<xref ref-type="bibr" rid="bib30">Duan et al., 2020</xref>). In contrast, most individuals following resolution of COVID-19 display a robust memory CD4+ and CD8+ T-cell response toward diverse SARS-CoV-2 viral proteins that are detectable for at least several months after symptom onset (<xref ref-type="bibr" rid="bib20">Cohen et al., 2021</xref>). Memory lymphocytes, however, can generally be divided into circulating memory cells, found in peripheral blood, and tissue-resident memory cells that reside in the non-lymphoid tissues (<xref ref-type="bibr" rid="bib41">Jarjour et al., 2021</xref>; <xref ref-type="bibr" rid="bib87">Weisberg et al., 2021</xref>). Shifts in the lymphocyte distribution leading to potentially reduced frequencies on SARS-CoV-2-specific effector cells in tissues or accumulation of exhausted effector cells in certain anatomic compartments, unable to control or clear the virus, could be considered as a potential mechanism for SARS-CoV-2 persistence in these ‘sanctuary sites.’ In fact, while nucleocapsid-specific antibody and T-cell responses were found to be elevated overall in individuals who developed Neuro-PASC, the severity of cognitive deficits or quality-of-life markers correlated with reduced effector molecule expression in memory T cells, suggesting a potential deficiency of these cells to clear the virus in the CNS compartment (<xref ref-type="bibr" rid="bib86">Visvabharathy et al., 2021</xref>). Consistently, nucleocapsid-specific IFNγ−/CD107a+ and IFNγ+CD8+T-cell responses decreased more rapidly in individuals with PASC than in convalescent controls, suggesting a dysfunctional immune response (perhaps in response to persistent antigen stimulation) as a contributor to the ongoing clinical syndrome (<xref ref-type="bibr" rid="bib61">Peluso et al., 2021</xref>). Alternatively, viral persistence in tissues might also serve as a chronic trigger for inflammation along with cellular activation that by itself might result in tissue damage causing PASC-related symptoms. Indeed, elevated frequencies of IFN-γ- and TNF-α-producing SARS-CoV-2-specific T cells in individuals with pulmonary PASC were found to be associated with increased systemic inflammation and decreased lung function, suggesting a potential pathogenic role of SARS-CoV-2-specific T cells, that is, via the production of inflammatory cytokines (<xref ref-type="bibr" rid="bib51">Littlefield et al., 2022</xref>). It therefore remains to be determined whether a lack of effector cells at immune-privileged anatomical compartments leads to viral persistence or whether viral persistence results in chronic immune activation with all its detrimental consequences, including lymphocyte overstimulation resulting in exhaustion complicated by worsening efficacy of the immune response to control or clear the virus. Comprehensive tissue studies in individuals suffering from PASC versus matched controls will therefore be critical to further investigate these questions.</p><p>Innate immune responses in PASC are complex and subject of ongoing in-depth studies. Multiple studies have demonstrated that antibodies generated against cytokines and chemokines correlate with COVID-19 severity and PASC, but a clear consensus on when these responses are protective or pathogenic has been elusive. It appears likely that early type I IFN responses are required for protection against severe acute disease, but delayed responses could be pathogenic (<xref ref-type="bibr" rid="bib16">Chiale et al., 2022</xref>). Chronic elevated expression of type I IFN and certain pro-inflammatory cytokines are known to cause neurological dysfunction and are found in PASC (<xref ref-type="bibr" rid="bib80">Tan et al., 2022</xref>). In addition, cellular transcriptional changes are observed in PASC versus non-PASC individuals after resolution of acute disease (<xref ref-type="bibr" rid="bib68">Ryan et al., 2022</xref>). It is possible that persistence of SARS-CoV-2 RNA and/or protein can lead to chronic activation of PAMPS and innate immune responses, resulting in some of the long-term symptoms found in PASC. Further studies should focus on these mechanisms and possible therapeutic approaches to intervene in the disease course. This topic is more thoroughly discussed in the accompanying review (‘Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection’).</p></sec><sec id="s2-4"><title>Long-term shedding and PASC</title><p>Many instances of long-term shedding of SARS-CoV-2 have been reported, even after resolution of symptomatic disease. It is possible that chronic production of live virus, viral RNA, or viral protein could lead to onset of PASC, as mentioned above. If this association is found, then monitoring patients post-infection for shedding would be a first step in identifying those at highest risk for long-term disease for potential intervention. Some efforts have been made to determine whether there is a correlation with PASC and viral shedding. One study reported that there was no association of SARS-CoV-2 shedding in saliva and onset of PASC (<xref ref-type="bibr" rid="bib61">Peluso et al., 2021</xref>). Viral RNA or antigen was found in the gastrointestinal tract of 7 of 14 asymptomatic individuals months after infection, but was not associated with tissue inflammation, suggesting that the presence of viral material alone may not be sufficient for PASC (<xref ref-type="bibr" rid="bib33">Gaebler et al., 2021</xref>). Conversely, there was an association between tissue persistence of genomic SARS-CoV-2 in olfactory mucosa and loss of smell in four patients, although no infected non-loss-of-smell controls were included in the study (<xref ref-type="bibr" rid="bib27">de Melo et al., 2021</xref>). A case report of a single individual demonstrated long-term viral RNA shedding of over 100 d in a patient with PASC affecting multiple organ systems (<xref ref-type="bibr" rid="bib59">Omololu et al., 2021</xref>), although there is a report of chronic shedding by PCR in a patient without long-term symptoms (<xref ref-type="bibr" rid="bib13">Chen et al., 2020</xref>).</p><p>Therefore, several questions remain regarding long-term SARS-CoV-2 shedding and PASC. First and foremost, is there a clear association between the two? One consideration in answering this question lies on the site of sample acquisition for viral shedding. Nasal swabs or saliva are the most accessible samples for monitoring long-term shedding, but it is possible that long-term viral shedding that occurs in the tissue(s) affected by PASC could be more informative. Furthermore, the nature of long-term SARS-CoV-2 shedding needs clarification: does long-term shedding represent only non-infectious genomic RNA or long-lived viral protein, or does it include live virus replication? Understanding the nature and location of long-term SARS-CoV-2 shedding could lead to insights with potential correlative effects with PASC onset.</p></sec><sec id="s2-5"><title>Role of non-neutralizing antibody responses in PASC</title><p>In some viral infections, antibodies that bind but do not neutralize the virus lead to antibody-dependent enhancement (ADE), a process that increases viral invasion of cells and leads to more severe pathogenesis (reviewed in <xref ref-type="bibr" rid="bib5">Arvin et al., 2020</xref>). In SARS-CoV-2 infection, neutralizing antibody responses wane rapidly, although binding antibodies persist (<xref ref-type="bibr" rid="bib3">Anand et al., 2021</xref>). Other antibody functions, such as directing other immune components to lyse-infected cells or engulf viral particles, are not well-explored in PASC.</p><p>ADE has been reported with several viral infections including dengue virus (DENV) and respiratory syncytial virus (RSV) (<xref ref-type="bibr" rid="bib24">Dejnirattisai et al., 2010</xref>; <xref ref-type="bibr" rid="bib45">Kim et al., 1969</xref>). ADE can be separated into type I ADE where enhanced antibody-mediated virus uptake into Fc gamma receptor (FcγR)-expressing phagocytic cells results in increased viral infection and replication, and into type II ADE, where disproportionate Fc-mediated effector cell activity as well as immune complex formation induce uncontrolled inflammation and immunopathology (type II ADE) (<xref ref-type="bibr" rid="bib47">Lee et al., 2020</xref>). Both versions of ADE can be observed when non-neutralizing antibodies or antibodies at sub-neutralizing levels bind to viral antigens without efficiently blocking or clearing the infection. Whether ADE plays a significant clinical role in COVID-19 is still undetermined, but the fact that millions have received COVID-19 vaccines and/or endured (repeated) SARS-CoV-2 infection without evidence of more enhanced disease in the setting of preexisting immunity argues against ADE being a significant contributor to SARS-CoV-2 pathogenesis overall. The question, however, has been raised whether ADE could be involved in the development of PASC, specifically in the setting of waning neutralizing antibody titers following acute infection. Indeed, there is ample evidence that neutralizing antibodies against SARS-CoV-2, either following natural infection or vaccination, decline overtime (<xref ref-type="bibr" rid="bib23">Cromer et al., 2022</xref>; <xref ref-type="bibr" rid="bib31">Evans et al., 2022</xref>; <xref ref-type="bibr" rid="bib50">Levin et al., 2021</xref>). Furthermore, a recent prospective cohort study of individuals with COVID-19 found that IgM and IgG3 levels during primary infection and after 6 months were lower among persons with PASC compared to those without (<xref ref-type="bibr" rid="bib11">Cervia et al., 2022</xref>), while another study did not find any difference in serial antibody levels between those who did and those who did not develop post-COVID-19 symptoms (<xref ref-type="bibr" rid="bib62">Pereira et al., 2021</xref>). Whether levels of non-neutralizing antibodies that are able to elicit Fc effector functions and potentially ADE are more stable in general in the circulation or whether such antibodies are enriched in specific anatomic compartments remains to be determined. As ADE requires viral antigen to be present, SARS-CoV-2 persistence in tissues together with insufficient neutralizing antibodies levels or elevated levels on non-neutralizing antibodies could theoretically trigger an ongoing inflammatory cascade; however, thus far, clear evidence for that concept is lacking. Therefore, the overall question of whether antibody-dependent enhancement of SARS-CoV-2 occurs in PASC, given the decreasing neutralizing responses after infection, needs to be answered.</p><p>Back-boosting of antibodies that recognize seasonal coronaviruses has been recognized early in the pandemic (<xref ref-type="bibr" rid="bib58">Ng et al., 2020</xref>) with one study reporting ∼20% of 251 tested individuals possessing non-neutralizing antibodies that cross-react with SARS-CoV-2 spike and nucleocapsid proteins prior to SARS-CoV-2 infection (<xref ref-type="bibr" rid="bib4">Anderson et al., 2021</xref>). The potential effects of such antibodies on COVID-19 severity still remain unclear. While some evidence suggests that prior exposure to seasonal coronaviruses could be protective against severe COVID-19 (<xref ref-type="bibr" rid="bib42">Kaplonek et al., 2021</xref>; <xref ref-type="bibr" rid="bib69">Sagar et al., 2021</xref>), other studies have found that antibody responses to seasonal coronaviruses were not associated with protection against SARS-CoV-2 infections or hospitalizations, or even enriched in severe COVID-19 (<xref ref-type="bibr" rid="bib2">Aguilar-Bretones et al., 2021</xref>; <xref ref-type="bibr" rid="bib4">Anderson et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Guo et al., 2021</xref>) and could potentially inhibit the formation of SARS-CoV-2-neutralizing and non-neutralizing antibodies (<xref ref-type="bibr" rid="bib6">Aydillo et al., 2021</xref>). Whether preexistent cross-reactive antibodies could play a role in the development of PASC has not been determined.</p></sec></sec><sec id="s3"><title>Reactivation of latent pathogens</title><sec id="s3-1"><title>Identification of reactivated viruses and other pathogens</title><p>An intriguing aspect of PASC is the discovery of reactivation of latent viruses after SARS-CoV-2 infection. It has been shown that EBV, a herpesvirus that infects a majority of individuals and is typically in a latent state, can be reactivated after SARS-CoV-2 infection (<xref ref-type="bibr" rid="bib14">Chen et al., 2021</xref>; <xref ref-type="bibr" rid="bib48">Lehner et al., 2020</xref>). Some studies have demonstrated a correlation between EBV reactivation and development of PASC (<xref ref-type="bibr" rid="bib37">Hao et al., 2021</xref>; <xref ref-type="bibr" rid="bib77">Su et al., 2022</xref>). There has been evidence of reactivation of other herpesviruses, including cytomegalovirus, herpes simplex virus 1, human herpesvirus 6, and human herpesvirus 7, in <italic>acute</italic> SARS-CoV-2 infection (<xref ref-type="bibr" rid="bib29">Drago et al., 2021</xref>; <xref ref-type="bibr" rid="bib48">Lehner et al., 2020</xref>; <xref ref-type="bibr" rid="bib77">Su et al., 2022</xref>; <xref ref-type="bibr" rid="bib90">Xu et al., 2020</xref>), although the association with these viruses and development of PASC has not been ascertained (<xref ref-type="bibr" rid="bib63">Proal and VanElzakker, 2021</xref>). Furthermore, some human endogenous retroviruses (HERVs) have been associated with more severe acute SARS-CoV-2 infection (<xref ref-type="bibr" rid="bib75">Simula et al., 2022</xref>; <xref ref-type="bibr" rid="bib82">Temerozo et al., 2022</xref>). Therefore, while a few herpesviruses are known to be reactivated in PASC and other viruses have been found to be upregulated in acute disease, identification of the full range of viral species or nonviral pathogens that can be reactivated or triggered has not been characterized. Performing plasma DNA PCR screening or RNA sequencing in samples from people with PASC should answer the question of which latent pathogens are reactivated in PASC versus non-PASC convalescent individuals. Specifically, what spectrum of viruses is reactivated in PASC? Also of interest is whether the timing of latent virus reactivation relative to symptomatic onset of PASC is relevant.</p></sec><sec id="s3-2"><title>Effects and mechanisms of latent viral reactivation in PASC</title><p>Given the known correlation between EBV reactivation and risk of developing PASC, an important question is the mechanism(s) involved in this process. Understanding of this mechanism is the first step in identifying potential interventions in at-risk individuals. Known mechanisms of EBV reactivation in non-COVID settings include host/viral miRNAs (<xref ref-type="bibr" rid="bib15">Chen et al., 2022</xref>), other viral genes, histone modifications, reactive oxygen species, the cellular stress response, and cell transcription factors binding to viral promoters (<xref ref-type="bibr" rid="bib71">Sausen et al., 2021</xref>). Other potential mechanisms include cytokine-mediated reactivation or loss of immune control. It is possible that if non-EBV latent pathogens are reactivated and associated with PASC, different reactivation pathways may be utilized.</p></sec><sec id="s3-3"><title>Role of immune responses against reactivated viruses in PASC</title><p>Reactivation of latent viruses has been linked to the dysregulation of the host immune response during acute SARS-CoV-2 infection, that is, by disabling the host type I interferon response via autoantibodies (<xref ref-type="bibr" rid="bib1">Acharya et al., 2020</xref>), resulting in decreased control of these latent pathogens. In fact, severely immunocompromised individuals are in general more prone to the reactivation of EBV. As an example, patients with respiratory failure admitted to the ICU have been shown to have more frequent EBV reactivation, and higher mortality in the setting of reduced CD8+ lymphocytes counts (<xref ref-type="bibr" rid="bib38">He et al., 2017</xref>). Nevertheless, these viruses were only detectable in blood during the acute phase of COVID-19 and reactivated viruses were so far not explicitly identified in individuals with PASC. Instead, EBV reactivation was determined by serology measuring viral capsid antigen (VCA) IgM and early antigen-diffuse (EA-D) IgG levels that increase as a consequence of viral activity (<xref ref-type="bibr" rid="bib34">Gold et al., 2021</xref>). It is therefore unclear whether there is a direct pathogenic effect of the latent viruses or whether a short phase of viral reactivation during acute SARS-CoV-2 infection induces additional inflammatory immune responses, contributing to the development of PASC. The finding of activated CMV-specific CD8+ T cells in individuals with gastrointestinal PASC has been attributed to bystander effect rather than a direct virally induced response as no detectable CMV viremia was observed (<xref ref-type="bibr" rid="bib77">Su et al., 2022</xref>). Evidence for a potential pathogenic role of immune responses against latent pathogens in PASC, however, comes from recent reports pointing to EBV as a possible causative agent in MS (<xref ref-type="bibr" rid="bib25">DeLorenze et al., 2006</xref>; <xref ref-type="bibr" rid="bib49">Levin et al., 2005</xref>) and specifically highlighting (EBV-specific) CD8+ T cells as these cells play a key role in antiviral immunity and dominate the CNS immune infiltrate in MS (<xref ref-type="bibr" rid="bib70">Salou et al., 2015</xref>; <xref ref-type="bibr" rid="bib84">van Nierop et al., 2016</xref>). Similarly, myocarditis or related cardiac inflammatory issues identified in some individuals with PASC after acute COVID-19 may be driven directly by SARS-CoV-2 but herpesviruses including HHV-6 have been described as the causes for virus-associated inflammatory cardiomyopathy (<xref ref-type="bibr" rid="bib83">Tschöpe et al., 2021</xref>). Whether virus-specific T-cell responses are contributing to the pathogenesis is insufficiently understood. Future studies will be needed to gain a deeper understanding of the interplay between the host immune response and reactivated latent pathogens and specifically to explore which triggers throw the usually fine-tuned interaction off balance.</p></sec><sec id="s3-4"><title>Conclusions</title><p>Identifying effective treatments for PASC and its many manifestations will be greatly aided by a better understanding of the role that viral persistence plays in different patients. Given the ability of coronaviruses to infect and reinfect individuals over a lifetime, viral persistence seems likely to play a role in PASC. There is ample evidence for persistence of SARS-CoV-2 viral RNA and proteins in several tissues, including respiratory tract, GI tract, olfactory mucosa, and the central nervous system. The mechanisms of persistence may involve replication or the action of viral replication machinery; however, exactly how viral components persist in individuals is still unclear. If persistence of antigen requires viral polymerase or protease, this provides a strong rationale for testing antivirals in patients. If the persistence is fully independent of replication, then it may be that vaccines that target more diverse genetic targets or other immunomodulators may be beneficial in targeting persistent virus.</p><p>The presence of persistent viral antigen and RNA may be the result of incomplete immunity where holes in the immune response permit viral persistence, but there also appears to be evidence that persistent inflammation as a reaction to persistent antigen is causing pathology. A deeper understanding of the adaptive immune responses, including T-cell and B-cell responses, may provide rationales for targeted therapies either to enhance clearance of persistent antigens, or to limit persistent inflammatory responses that are causing damage.</p><p>The evidence for reactivation of other latent viruses also appears to be implicated; these provide a rationale for more extended testing for reactivation of EBV and other viruses during PASC or similar post-viral syndromes. Treatment of these viral co-infections may also provide an avenue for therapeutic trials where evidence of persistent viral activation is present.</p><p>A major challenge of the treatment of PASC is that it appears to be a highly diverse condition, potentially with several different pathogenetic mechanisms that each will require a distinct treatment approach. Tissue sampling and studies are also particularly important to have a true understanding of the presence and role of viral persistence. Deeper explorations of the mechanisms of viral persistence should aid in the design of clinical trials to match symptoms with trials of drugs that can target specific pathogenic pathways. Studies such as RECOVER that have comprehensive and longitudinal patient data and samples can help answer some of the questions raised above.</p></sec></sec></body><back><sec sec-type="additional-information" id="s4"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Resources, Software, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Resources, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Resources, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization</p></fn></fn-group></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by the Researching Covid to Enhance Recovery (RECOVER) Initiative (OT2HL161847-01) through the American Rescue Plan Act of 2021 (Sec. 2401). RECOVER seeks to understand, treat, and prevent the post-acute sequelae of SARS-CoV-2 infection (PASC). We would like to thank the National Community Engagement Group (NCEG), all patient, caregiver, and community Representatives, and all the participants enrolled in the RECOVER Initiative. This work was made possible through support from the National Institutes of Health, New York University Langone Health, Research Triangle Institute, and the RECOVER Initiative’s Mechanistic Pathways task force. We thank Huaqin (Helen) Pan for assistance with manuscript organization and reference collection. This content is solely the responsibility of the authors and does not necessarily represent the official views of the RECOVER Program, the NIH, or other funders. This research was funded by the National Institutes of Health (NIH) Agreement OTA OT2HL161847 (contract number 01) as part of the Researching COVID to Enhance Recovery (RECOVER) research program.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acharya</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Gack</surname><given-names>MU</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Dysregulation of type I interferon responses in COVID-19</article-title><source>Nature Reviews. Immunology</source><volume>20</volume><fpage>397</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-0346-x</pub-id><pub-id pub-id-type="pmid">32457522</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar-Bretones</surname><given-names>M</given-names></name><name><surname>Westerhuis</surname><given-names>BM</given-names></name><name><surname>Raadsen</surname><given-names>MP</given-names></name><name><surname>de Bruin</surname><given-names>E</given-names></name><name><surname>Chandler</surname><given-names>FD</given-names></name><name><surname>Okba</surname><given-names>NM</given-names></name><name><surname>Haagmans</surname><given-names>BL</given-names></name><name><surname>Langerak</surname><given-names>T</given-names></name><name><surname>Endeman</surname><given-names>H</given-names></name><name><surname>van den Akker</surname><given-names>JP</given-names></name><name><surname>Gommers</surname><given-names>DA</given-names></name><name><surname>van Gorp</surname><given-names>EC</given-names></name><name><surname>GeurtsvanKessel</surname><given-names>CH</given-names></name><name><surname>de Vries</surname><given-names>RD</given-names></name><name><surname>Fouchier</surname><given-names>RA</given-names></name><name><surname>Rockx</surname><given-names>BH</given-names></name><name><surname>Koopmans</surname><given-names>MP</given-names></name><name><surname>van Nierop</surname><given-names>GP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Seasonal Coronavirus-specific B cells with limited SARS-Cov-2 cross-reactivity dominate the IgG response in severe COVID-19</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>e150613</elocation-id><pub-id pub-id-type="doi">10.1172/JCI150613</pub-id><pub-id pub-id-type="pmid">34499051</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>SP</given-names></name><name><surname>Prévost</surname><given-names>J</given-names></name><name><surname>Nayrac</surname><given-names>M</given-names></name><name><surname>Beaudoin-Bussières</surname><given-names>G</given-names></name><name><surname>Benlarbi</surname><given-names>M</given-names></name><name><surname>Gasser</surname><given-names>R</given-names></name><name><surname>Brassard</surname><given-names>N</given-names></name><name><surname>Laumaea</surname><given-names>A</given-names></name><name><surname>Gong</surname><given-names>SY</given-names></name><name><surname>Bourassa</surname><given-names>C</given-names></name><name><surname>Brunet-Ratnasingham</surname><given-names>E</given-names></name><name><surname>Medjahed</surname><given-names>H</given-names></name><name><surname>Gendron-Lepage</surname><given-names>G</given-names></name><name><surname>Goyette</surname><given-names>G</given-names></name><name><surname>Gokool</surname><given-names>L</given-names></name><name><surname>Morrisseau</surname><given-names>C</given-names></name><name><surname>Bégin</surname><given-names>P</given-names></name><name><surname>Martel-Laferrière</surname><given-names>V</given-names></name><name><surname>Tremblay</surname><given-names>C</given-names></name><name><surname>Richard</surname><given-names>J</given-names></name><name><surname>Bazin</surname><given-names>R</given-names></name><name><surname>Duerr</surname><given-names>R</given-names></name><name><surname>Kaufmann</surname><given-names>DE</given-names></name><name><surname>Finzi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Longitudinal analysis of humoral immunity against SARS-Cov-2 spike in Convalescent individuals up to 8 months post-symptom onset</article-title><source>Cell Reports. Medicine</source><volume>2</volume><elocation-id>100290</elocation-id><pub-id pub-id-type="doi">10.1016/j.xcrm.2021.100290</pub-id><pub-id pub-id-type="pmid">33969322</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>EM</given-names></name><name><surname>Goodwin</surname><given-names>EC</given-names></name><name><surname>Verma</surname><given-names>A</given-names></name><name><surname>Arevalo</surname><given-names>CP</given-names></name><name><surname>Bolton</surname><given-names>MJ</given-names></name><name><surname>Weirick</surname><given-names>ME</given-names></name><name><surname>Gouma</surname><given-names>S</given-names></name><name><surname>McAllister</surname><given-names>CM</given-names></name><name><surname>Christensen</surname><given-names>SR</given-names></name><name><surname>Weaver</surname><given-names>J</given-names></name><name><surname>Hicks</surname><given-names>P</given-names></name><name><surname>Manzoni</surname><given-names>TB</given-names></name><name><surname>Oniyide</surname><given-names>O</given-names></name><name><surname>Ramage</surname><given-names>H</given-names></name><name><surname>Mathew</surname><given-names>D</given-names></name><name><surname>Baxter</surname><given-names>AE</given-names></name><name><surname>Oldridge</surname><given-names>DA</given-names></name><name><surname>Greenplate</surname><given-names>AR</given-names></name><name><surname>Wu</surname><given-names>JE</given-names></name><name><surname>Alanio</surname><given-names>C</given-names></name><name><surname>D’Andrea</surname><given-names>K</given-names></name><name><surname>Kuthuru</surname><given-names>O</given-names></name><name><surname>Dougherty</surname><given-names>J</given-names></name><name><surname>Pattekar</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>N</given-names></name><name><surname>Apostolidis</surname><given-names>SA</given-names></name><name><surname>Huang</surname><given-names>AC</given-names></name><name><surname>Vella</surname><given-names>LA</given-names></name><name><surname>Kuri-Cervantes</surname><given-names>L</given-names></name><name><surname>Pampena</surname><given-names>MB</given-names></name><name><surname>Betts</surname><given-names>MR</given-names></name><name><surname>Wherry</surname><given-names>EJ</given-names></name><name><surname>Meyer</surname><given-names>NJ</given-names></name><name><surname>Cherry</surname><given-names>S</given-names></name><name><surname>Bates</surname><given-names>P</given-names></name><name><surname>Rader</surname><given-names>DJ</given-names></name><name><surname>Hensley</surname><given-names>SE</given-names></name><collab>UPenn COVID Processing Unit</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Seasonal human Coronavirus antibodies are boosted upon SARS-Cov-2 infection but not associated with protection</article-title><source>Cell</source><volume>184</volume><fpage>1858</fpage><lpage>1864</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.02.010</pub-id><pub-id pub-id-type="pmid">33631096</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arvin</surname><given-names>AM</given-names></name><name><surname>Fink</surname><given-names>K</given-names></name><name><surname>Schmid</surname><given-names>MA</given-names></name><name><surname>Cathcart</surname><given-names>A</given-names></name><name><surname>Spreafico</surname><given-names>R</given-names></name><name><surname>Havenar-Daughton</surname><given-names>C</given-names></name><name><surname>Lanzavecchia</surname><given-names>A</given-names></name><name><surname>Corti</surname><given-names>D</given-names></name><name><surname>Virgin</surname><given-names>HW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A perspective on potential antibody-dependent enhancement of SARS-Cov-2</article-title><source>Nature</source><volume>584</volume><fpage>353</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2538-8</pub-id><pub-id pub-id-type="pmid">32659783</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aydillo</surname><given-names>T</given-names></name><name><surname>Rombauts</surname><given-names>A</given-names></name><name><surname>Stadlbauer</surname><given-names>D</given-names></name><name><surname>Aslam</surname><given-names>S</given-names></name><name><surname>Abelenda-Alonso</surname><given-names>G</given-names></name><name><surname>Escalera</surname><given-names>A</given-names></name><name><surname>Amanat</surname><given-names>F</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Krammer</surname><given-names>F</given-names></name><name><surname>Carratala</surname><given-names>J</given-names></name><name><surname>García-Sastre</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Immunological Imprinting of the antibody response in COVID-19 patients</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>3781</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-23977-1</pub-id><pub-id pub-id-type="pmid">34145263</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannister</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Post-infectious disease syndrome</article-title><source>Postgraduate Medical Journal</source><volume>64</volume><fpage>559</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1136/pgmj.64.753.559</pub-id><pub-id pub-id-type="pmid">3074289</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilich</surname><given-names>T</given-names></name><name><surname>Nelde</surname><given-names>A</given-names></name><name><surname>Heitmann</surname><given-names>JS</given-names></name><name><surname>Maringer</surname><given-names>Y</given-names></name><name><surname>Roerden</surname><given-names>M</given-names></name><name><surname>Bauer</surname><given-names>J</given-names></name><name><surname>Rieth</surname><given-names>J</given-names></name><name><surname>Wacker</surname><given-names>M</given-names></name><name><surname>Peter</surname><given-names>A</given-names></name><name><surname>Hörber</surname><given-names>S</given-names></name><name><surname>Rachfalski</surname><given-names>D</given-names></name><name><surname>Märklin</surname><given-names>M</given-names></name><name><surname>Stevanović</surname><given-names>S</given-names></name><name><surname>Rammensee</surname><given-names>H-G</given-names></name><name><surname>Salih</surname><given-names>HR</given-names></name><name><surname>Walz</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>T cell and antibody Kinetics delineate SARS-Cov-2 peptides mediating long-term immune responses in COVID-19 Convalescent individuals</article-title><source>Science Translational Medicine</source><volume>13</volume><elocation-id>eabf7517</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abf7517</pub-id><pub-id pub-id-type="pmid">33723016</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bullard</surname><given-names>J</given-names></name><name><surname>Dust</surname><given-names>K</given-names></name><name><surname>Funk</surname><given-names>D</given-names></name><name><surname>Strong</surname><given-names>JE</given-names></name><name><surname>Alexander</surname><given-names>D</given-names></name><name><surname>Garnett</surname><given-names>L</given-names></name><name><surname>Boodman</surname><given-names>C</given-names></name><name><surname>Bello</surname><given-names>A</given-names></name><name><surname>Hedley</surname><given-names>A</given-names></name><name><surname>Schiffman</surname><given-names>Z</given-names></name><name><surname>Doan</surname><given-names>K</given-names></name><name><surname>Bastien</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Van Caeseele</surname><given-names>PG</given-names></name><name><surname>Poliquin</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Predicting infectious severe acute respiratory syndrome Coronavirus 2 from diagnostic samples</article-title><source>Clinical Infectious Diseases</source><volume>71</volume><fpage>2663</fpage><lpage>2666</lpage><pub-id pub-id-type="doi">10.1093/cid/ciaa638</pub-id><pub-id pub-id-type="pmid">32442256</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassedy</surname><given-names>A</given-names></name><name><surname>Parle-McDermott</surname><given-names>A</given-names></name><name><surname>O’Kennedy</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Virus detection: A review of the current and emerging molecular and immunological methods</article-title><source>Frontiers in Molecular Biosciences</source><volume>8</volume><elocation-id>637559</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2021.637559</pub-id><pub-id pub-id-type="pmid">33959631</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cervia</surname><given-names>C</given-names></name><name><surname>Zurbuchen</surname><given-names>Y</given-names></name><name><surname>Taeschler</surname><given-names>P</given-names></name><name><surname>Ballouz</surname><given-names>T</given-names></name><name><surname>Menges</surname><given-names>D</given-names></name><name><surname>Hasler</surname><given-names>S</given-names></name><name><surname>Adamo</surname><given-names>S</given-names></name><name><surname>Raeber</surname><given-names>ME</given-names></name><name><surname>Bächli</surname><given-names>E</given-names></name><name><surname>Rudiger</surname><given-names>A</given-names></name><name><surname>Stüssi-Helbling</surname><given-names>M</given-names></name><name><surname>Huber</surname><given-names>LC</given-names></name><name><surname>Nilsson</surname><given-names>J</given-names></name><name><surname>Held</surname><given-names>U</given-names></name><name><surname>Puhan</surname><given-names>MA</given-names></name><name><surname>Boyman</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>446</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-27797-1</pub-id><pub-id pub-id-type="pmid">35078982</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cevik</surname><given-names>M</given-names></name><name><surname>Tate</surname><given-names>M</given-names></name><name><surname>Lloyd</surname><given-names>O</given-names></name><name><surname>Maraolo</surname><given-names>AE</given-names></name><name><surname>Schafers</surname><given-names>J</given-names></name><name><surname>Ho</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>SARS-Cov-2, SARS-Cov, and MERS-Cov viral load Dynamics, duration of viral shedding, and Infectiousness: A systematic review and meta-analysis</article-title><source>The Lancet. Microbe</source><volume>2</volume><fpage>e13</fpage><lpage>e22</lpage><pub-id pub-id-type="doi">10.1016/S2666-5247(20)30172-5</pub-id><pub-id pub-id-type="pmid">33521734</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Yi</surname><given-names>C</given-names></name><name><surname>Chi</surname><given-names>Y</given-names></name><name><surname>Xiong</surname><given-names>Q</given-names></name><name><surname>Tan</surname><given-names>CW</given-names></name><name><surname>Yi</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>LF</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>An unusual COVID-19 case with over four months of viral shedding in the presence of low neutralizing antibodies: A case report</article-title><source>Journal of Biomedical Research</source><volume>34</volume><fpage>470</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.7555/JBR.34.20200099</pub-id><pub-id pub-id-type="pmid">33243942</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Positive Epstein-Barr virus detection in Coronavirus disease 2019 (COVID-19) patients</article-title><source>Scientific Reports</source><volume>11</volume><elocation-id>10902</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-021-90351-y</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Microrna regulation of human Herpesvirus latency</article-title><source>Viruses</source><volume>14</volume><elocation-id>1215</elocation-id><pub-id pub-id-type="doi">10.3390/v14061215</pub-id><pub-id pub-id-type="pmid">35746686</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiale</surname><given-names>C</given-names></name><name><surname>Greene</surname><given-names>TT</given-names></name><name><surname>Zuniga</surname><given-names>EI</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Interferon induction, evasion, and paradoxical roles during SARS-Cov-2 infection</article-title><source>Immunological Reviews</source><volume>309</volume><fpage>12</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1111/imr.13113</pub-id><pub-id pub-id-type="pmid">35775361</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>A</given-names></name><name><surname>Muecksch</surname><given-names>F</given-names></name><name><surname>Schaefer-Babajew</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Finkin</surname><given-names>S</given-names></name><name><surname>Gaebler</surname><given-names>C</given-names></name><name><surname>Ramos</surname><given-names>V</given-names></name><name><surname>Cipolla</surname><given-names>M</given-names></name><name><surname>Mendoza</surname><given-names>P</given-names></name><name><surname>Agudelo</surname><given-names>M</given-names></name><name><surname>Bednarski</surname><given-names>E</given-names></name><name><surname>DaSilva</surname><given-names>J</given-names></name><name><surname>Shimeliovich</surname><given-names>I</given-names></name><name><surname>Dizon</surname><given-names>J</given-names></name><name><surname>Daga</surname><given-names>M</given-names></name><name><surname>Millard</surname><given-names>KG</given-names></name><name><surname>Turroja</surname><given-names>M</given-names></name><name><surname>Schmidt</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Tanfous</surname><given-names>TB</given-names></name><name><surname>Jankovic</surname><given-names>M</given-names></name><name><surname>Oliveria</surname><given-names>TY</given-names></name><name><surname>Gazumyan</surname><given-names>A</given-names></name><name><surname>Caskey</surname><given-names>M</given-names></name><name><surname>Bieniasz</surname><given-names>PD</given-names></name><name><surname>Hatziioannou</surname><given-names>T</given-names></name><name><surname>Nussenzweig</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Anti-SARS-Cov-2 receptor-binding domain antibody evolution after mRNA vaccination</article-title><source>Nature</source><volume>600</volume><fpage>517</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-04060-7</pub-id><pub-id pub-id-type="pmid">34619745</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>DV</given-names></name><name><surname>Kibuuka</surname><given-names>H</given-names></name><name><surname>Millard</surname><given-names>M</given-names></name><name><surname>Wakabi</surname><given-names>S</given-names></name><name><surname>Lukwago</surname><given-names>L</given-names></name><name><surname>Taylor</surname><given-names>A</given-names></name><name><surname>Eller</surname><given-names>MA</given-names></name><name><surname>Eller</surname><given-names>LA</given-names></name><name><surname>Michael</surname><given-names>NL</given-names></name><name><surname>Honko</surname><given-names>AN</given-names></name><name><surname>Olinger</surname><given-names>GG</given-names></name><name><surname>Schoepp</surname><given-names>RJ</given-names></name><name><surname>Hepburn</surname><given-names>MJ</given-names></name><name><surname>Hensley</surname><given-names>LE</given-names></name><name><surname>Robb</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: A retrospective cohort study</article-title><source>The Lancet. Infectious Diseases</source><volume>15</volume><fpage>905</fpage><lpage>912</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(15)70152-0</pub-id><pub-id pub-id-type="pmid">25910637</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clausen</surname><given-names>TM</given-names></name><name><surname>Sandoval</surname><given-names>DR</given-names></name><name><surname>Spliid</surname><given-names>CB</given-names></name><name><surname>Pihl</surname><given-names>J</given-names></name><name><surname>Perrett</surname><given-names>HR</given-names></name><name><surname>Painter</surname><given-names>CD</given-names></name><name><surname>Narayanan</surname><given-names>A</given-names></name><name><surname>Majowicz</surname><given-names>SA</given-names></name><name><surname>Kwong</surname><given-names>EM</given-names></name><name><surname>McVicar</surname><given-names>RN</given-names></name><name><surname>Thacker</surname><given-names>BE</given-names></name><name><surname>Glass</surname><given-names>CA</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Torres</surname><given-names>JL</given-names></name><name><surname>Golden</surname><given-names>GJ</given-names></name><name><surname>Bartels</surname><given-names>PL</given-names></name><name><surname>Porell</surname><given-names>RN</given-names></name><name><surname>Garretson</surname><given-names>AF</given-names></name><name><surname>Laubach</surname><given-names>L</given-names></name><name><surname>Feldman</surname><given-names>J</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Pu</surname><given-names>Y</given-names></name><name><surname>Hauser</surname><given-names>BM</given-names></name><name><surname>Caradonna</surname><given-names>TM</given-names></name><name><surname>Kellman</surname><given-names>BP</given-names></name><name><surname>Martino</surname><given-names>C</given-names></name><name><surname>Gordts</surname><given-names>PLSM</given-names></name><name><surname>Chanda</surname><given-names>SK</given-names></name><name><surname>Schmidt</surname><given-names>AG</given-names></name><name><surname>Godula</surname><given-names>K</given-names></name><name><surname>Leibel</surname><given-names>SL</given-names></name><name><surname>Jose</surname><given-names>J</given-names></name><name><surname>Corbett</surname><given-names>KD</given-names></name><name><surname>Ward</surname><given-names>AB</given-names></name><name><surname>Carlin</surname><given-names>AF</given-names></name><name><surname>Esko</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-Cov-2 infection depends on cellular Heparan sulfate and Ace2</article-title><source>Cell</source><volume>183</volume><fpage>1043</fpage><lpage>1057</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.09.033</pub-id><pub-id pub-id-type="pmid">32970989</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>KW</given-names></name><name><surname>Linderman</surname><given-names>SL</given-names></name><name><surname>Moodie</surname><given-names>Z</given-names></name><name><surname>Czartoski</surname><given-names>J</given-names></name><name><surname>Lai</surname><given-names>L</given-names></name><name><surname>Mantus</surname><given-names>G</given-names></name><name><surname>Norwood</surname><given-names>C</given-names></name><name><surname>Nyhoff</surname><given-names>LE</given-names></name><name><surname>Edara</surname><given-names>VV</given-names></name><name><surname>Floyd</surname><given-names>K</given-names></name><name><surname>De Rosa</surname><given-names>SC</given-names></name><name><surname>Ahmed</surname><given-names>H</given-names></name><name><surname>Whaley</surname><given-names>R</given-names></name><name><surname>Patel</surname><given-names>SN</given-names></name><name><surname>Prigmore</surname><given-names>B</given-names></name><name><surname>Lemos</surname><given-names>MP</given-names></name><name><surname>Davis</surname><given-names>CW</given-names></name><name><surname>Furth</surname><given-names>S</given-names></name><name><surname>O’Keefe</surname><given-names>JB</given-names></name><name><surname>Gharpure</surname><given-names>MP</given-names></name><name><surname>Gunisetty</surname><given-names>S</given-names></name><name><surname>Stephens</surname><given-names>K</given-names></name><name><surname>Antia</surname><given-names>R</given-names></name><name><surname>Zarnitsyna</surname><given-names>VI</given-names></name><name><surname>Stephens</surname><given-names>DS</given-names></name><name><surname>Edupuganti</surname><given-names>S</given-names></name><name><surname>Rouphael</surname><given-names>N</given-names></name><name><surname>Anderson</surname><given-names>EJ</given-names></name><name><surname>Mehta</surname><given-names>AK</given-names></name><name><surname>Wrammert</surname><given-names>J</given-names></name><name><surname>Suthar</surname><given-names>MS</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name><name><surname>McElrath</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Longitudinal analysis shows durable and broad immune memory after SARS-Cov-2 infection with persisting antibody responses and memory B and T cells</article-title><source>Cell Reports. Medicine</source><volume>2</volume><elocation-id>100354</elocation-id><pub-id pub-id-type="doi">10.1016/j.xcrm.2021.100354</pub-id><pub-id pub-id-type="pmid">34250512</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Craddock</surname><given-names>V</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Krishnamachary</surname><given-names>B</given-names></name><name><surname>Spikes</surname><given-names>L</given-names></name><name><surname>Chalise</surname><given-names>P</given-names></name><name><surname>Dhillon</surname><given-names>NK</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Persistent presence of spike protein and viral RNA in the circulation of individuals with post-acute sequelae of COVID-19</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2022.08.07.22278520</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craddock</surname><given-names>V</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Spikes</surname><given-names>L</given-names></name><name><surname>Krishnamachary</surname><given-names>B</given-names></name><name><surname>Ram</surname><given-names>AK</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Chalise</surname><given-names>P</given-names></name><name><surname>Dhillon</surname><given-names>NK</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Persistent circulation of soluble and extracellular Vesicle-linked spike protein in individuals with Postacute sequelae of COVID-19</article-title><source>Journal of Medical Virology</source><volume>95</volume><elocation-id>e28568</elocation-id><pub-id pub-id-type="doi">10.1002/jmv.28568</pub-id><pub-id pub-id-type="pmid">36756925</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cromer</surname><given-names>D</given-names></name><name><surname>Steain</surname><given-names>M</given-names></name><name><surname>Reynaldi</surname><given-names>A</given-names></name><name><surname>Schlub</surname><given-names>TE</given-names></name><name><surname>Wheatley</surname><given-names>AK</given-names></name><name><surname>Juno</surname><given-names>JA</given-names></name><name><surname>Kent</surname><given-names>SJ</given-names></name><name><surname>Triccas</surname><given-names>JA</given-names></name><name><surname>Khoury</surname><given-names>DS</given-names></name><name><surname>Davenport</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Neutralising antibody Titres as predictors of protection against SARS-Cov-2 variants and the impact of boosting: A meta-analysis</article-title><source>The Lancet. Microbe</source><volume>3</volume><fpage>e52</fpage><lpage>e61</lpage><pub-id pub-id-type="doi">10.1016/S2666-5247(21)00267-6</pub-id><pub-id pub-id-type="pmid">34806056</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dejnirattisai</surname><given-names>W</given-names></name><name><surname>Jumnainsong</surname><given-names>A</given-names></name><name><surname>Onsirisakul</surname><given-names>N</given-names></name><name><surname>Fitton</surname><given-names>P</given-names></name><name><surname>Vasanawathana</surname><given-names>S</given-names></name><name><surname>Limpitikul</surname><given-names>W</given-names></name><name><surname>Puttikhunt</surname><given-names>C</given-names></name><name><surname>Edwards</surname><given-names>C</given-names></name><name><surname>Duangchinda</surname><given-names>T</given-names></name><name><surname>Supasa</surname><given-names>S</given-names></name><name><surname>Chawansuntati</surname><given-names>K</given-names></name><name><surname>Malasit</surname><given-names>P</given-names></name><name><surname>Mongkolsapaya</surname><given-names>J</given-names></name><name><surname>Screaton</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cross-reacting antibodies enhance Dengue virus infection in humans</article-title><source>Science</source><volume>328</volume><fpage>745</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1126/science.1185181</pub-id><pub-id pub-id-type="pmid">20448183</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLorenze</surname><given-names>GN</given-names></name><name><surname>Munger</surname><given-names>KL</given-names></name><name><surname>Lennette</surname><given-names>ET</given-names></name><name><surname>Orentreich</surname><given-names>N</given-names></name><name><surname>Vogelman</surname><given-names>JH</given-names></name><name><surname>Ascherio</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up</article-title><source>Archives of Neurology</source><volume>63</volume><fpage>839</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1001/archneur.63.6.noc50328</pub-id><pub-id pub-id-type="pmid">16606758</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delorey</surname><given-names>TM</given-names></name><name><surname>Ziegler</surname><given-names>CGK</given-names></name><name><surname>Heimberg</surname><given-names>G</given-names></name><name><surname>Normand</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Segerstolpe</surname><given-names>Å</given-names></name><name><surname>Abbondanza</surname><given-names>D</given-names></name><name><surname>Fleming</surname><given-names>SJ</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Montoro</surname><given-names>DT</given-names></name><name><surname>Jagadeesh</surname><given-names>KA</given-names></name><name><surname>Dey</surname><given-names>KK</given-names></name><name><surname>Sen</surname><given-names>P</given-names></name><name><surname>Slyper</surname><given-names>M</given-names></name><name><surname>Pita-Juárez</surname><given-names>YH</given-names></name><name><surname>Phillips</surname><given-names>D</given-names></name><name><surname>Biermann</surname><given-names>J</given-names></name><name><surname>Bloom-Ackermann</surname><given-names>Z</given-names></name><name><surname>Barkas</surname><given-names>N</given-names></name><name><surname>Ganna</surname><given-names>A</given-names></name><name><surname>Gomez</surname><given-names>J</given-names></name><name><surname>Melms</surname><given-names>JC</given-names></name><name><surname>Katsyv</surname><given-names>I</given-names></name><name><surname>Normandin</surname><given-names>E</given-names></name><name><surname>Naderi</surname><given-names>P</given-names></name><name><surname>Popov</surname><given-names>YV</given-names></name><name><surname>Raju</surname><given-names>SS</given-names></name><name><surname>Niezen</surname><given-names>S</given-names></name><name><surname>Tsai</surname><given-names>LTY</given-names></name><name><surname>Siddle</surname><given-names>KJ</given-names></name><name><surname>Sud</surname><given-names>M</given-names></name><name><surname>Tran</surname><given-names>VM</given-names></name><name><surname>Vellarikkal</surname><given-names>SK</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Amir-Zilberstein</surname><given-names>L</given-names></name><name><surname>Atri</surname><given-names>DS</given-names></name><name><surname>Beechem</surname><given-names>J</given-names></name><name><surname>Brook</surname><given-names>OR</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Divakar</surname><given-names>P</given-names></name><name><surname>Dorceus</surname><given-names>P</given-names></name><name><surname>Engreitz</surname><given-names>JM</given-names></name><name><surname>Essene</surname><given-names>A</given-names></name><name><surname>Fitzgerald</surname><given-names>DM</given-names></name><name><surname>Fropf</surname><given-names>R</given-names></name><name><surname>Gazal</surname><given-names>S</given-names></name><name><surname>Gould</surname><given-names>J</given-names></name><name><surname>Grzyb</surname><given-names>J</given-names></name><name><surname>Harvey</surname><given-names>T</given-names></name><name><surname>Hecht</surname><given-names>J</given-names></name><name><surname>Hether</surname><given-names>T</given-names></name><name><surname>Jané-Valbuena</surname><given-names>J</given-names></name><name><surname>Leney-Greene</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>McCabe</surname><given-names>C</given-names></name><name><surname>McLoughlin</surname><given-names>DE</given-names></name><name><surname>Miller</surname><given-names>EM</given-names></name><name><surname>Muus</surname><given-names>C</given-names></name><name><surname>Niemi</surname><given-names>M</given-names></name><name><surname>Padera</surname><given-names>R</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name><name><surname>Pant</surname><given-names>D</given-names></name><name><surname>Pe’er</surname><given-names>C</given-names></name><name><surname>Pfiffner-Borges</surname><given-names>J</given-names></name><name><surname>Pinto</surname><given-names>CJ</given-names></name><name><surname>Plaisted</surname><given-names>J</given-names></name><name><surname>Reeves</surname><given-names>J</given-names></name><name><surname>Ross</surname><given-names>M</given-names></name><name><surname>Rudy</surname><given-names>M</given-names></name><name><surname>Rueckert</surname><given-names>EH</given-names></name><name><surname>Siciliano</surname><given-names>M</given-names></name><name><surname>Sturm</surname><given-names>A</given-names></name><name><surname>Todres</surname><given-names>E</given-names></name><name><surname>Waghray</surname><given-names>A</given-names></name><name><surname>Warren</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zollinger</surname><given-names>DR</given-names></name><name><surname>Cosimi</surname><given-names>L</given-names></name><name><surname>Gupta</surname><given-names>RM</given-names></name><name><surname>Hacohen</surname><given-names>N</given-names></name><name><surname>Hibshoosh</surname><given-names>H</given-names></name><name><surname>Hide</surname><given-names>W</given-names></name><name><surname>Price</surname><given-names>AL</given-names></name><name><surname>Rajagopal</surname><given-names>J</given-names></name><name><surname>Tata</surname><given-names>PR</given-names></name><name><surname>Riedel</surname><given-names>S</given-names></name><name><surname>Szabo</surname><given-names>G</given-names></name><name><surname>Tickle</surname><given-names>TL</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><name><surname>Hung</surname><given-names>D</given-names></name><name><surname>Sabeti</surname><given-names>PC</given-names></name><name><surname>Novak</surname><given-names>R</given-names></name><name><surname>Rogers</surname><given-names>R</given-names></name><name><surname>Ingber</surname><given-names>DE</given-names></name><name><surname>Jiang</surname><given-names>ZG</given-names></name><name><surname>Juric</surname><given-names>D</given-names></name><name><surname>Babadi</surname><given-names>M</given-names></name><name><surname>Farhi</surname><given-names>SL</given-names></name><name><surname>Izar</surname><given-names>B</given-names></name><name><surname>Stone</surname><given-names>JR</given-names></name><name><surname>Vlachos</surname><given-names>IS</given-names></name><name><surname>Solomon</surname><given-names>IH</given-names></name><name><surname>Ashenberg</surname><given-names>O</given-names></name><name><surname>Porter</surname><given-names>CBM</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Shalek</surname><given-names>AK</given-names></name><name><surname>Villani</surname><given-names>AC</given-names></name><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>COVID-19 tissue atlases reveal sars-cov-2 pathology and cellular targets</article-title><source>Nature</source><volume>595</volume><fpage>107</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03570-8</pub-id><pub-id pub-id-type="pmid">33915569</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Melo</surname><given-names>GD</given-names></name><name><surname>Lazarini</surname><given-names>F</given-names></name><name><surname>Levallois</surname><given-names>S</given-names></name><name><surname>Hautefort</surname><given-names>C</given-names></name><name><surname>Michel</surname><given-names>V</given-names></name><name><surname>Larrous</surname><given-names>F</given-names></name><name><surname>Verillaud</surname><given-names>B</given-names></name><name><surname>Aparicio</surname><given-names>C</given-names></name><name><surname>Wagner</surname><given-names>S</given-names></name><name><surname>Gheusi</surname><given-names>G</given-names></name><name><surname>Kergoat</surname><given-names>L</given-names></name><name><surname>Kornobis</surname><given-names>E</given-names></name><name><surname>Donati</surname><given-names>F</given-names></name><name><surname>Cokelaer</surname><given-names>T</given-names></name><name><surname>Hervochon</surname><given-names>R</given-names></name><name><surname>Madec</surname><given-names>Y</given-names></name><name><surname>Roze</surname><given-names>E</given-names></name><name><surname>Salmon</surname><given-names>D</given-names></name><name><surname>Bourhy</surname><given-names>H</given-names></name><name><surname>Lecuit</surname><given-names>M</given-names></name><name><surname>Lledo</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters</article-title><source>Science Translational Medicine</source><volume>13</volume><elocation-id>eabf8396</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abf8396</pub-id><pub-id pub-id-type="pmid">33941622</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Ning</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (covid-19)</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>827</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.00827</pub-id><pub-id pub-id-type="pmid">32425950</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drago</surname><given-names>F</given-names></name><name><surname>Ciccarese</surname><given-names>G</given-names></name><name><surname>Rebora</surname><given-names>A</given-names></name><name><surname>Parodi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Human Herpesvirus-6, -7, and Epstein-Barr virus reactivation in Pityriasis Rosea during COVID-19</article-title><source>Journal of Medical Virology</source><volume>93</volume><fpage>1850</fpage><lpage>1851</lpage><pub-id pub-id-type="doi">10.1002/jmv.26549</pub-id><pub-id pub-id-type="pmid">32970319</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>Y-Q</given-names></name><name><surname>Xia</surname><given-names>M-H</given-names></name><name><surname>Ren</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y-F</given-names></name><name><surname>Ao</surname><given-names>Q-L</given-names></name><name><surname>Xu</surname><given-names>S-P</given-names></name><name><surname>Kuang</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Yan</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>Y-W</given-names></name><name><surname>Chu</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>X-P</given-names></name><name><surname>Wang</surname><given-names>G-P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Deficiency of Tfh cells and germinal center in deceased COVID-19 patients</article-title><source>Current Medical Science</source><volume>40</volume><fpage>618</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1007/s11596-020-2225-x</pub-id><pub-id pub-id-type="pmid">32767259</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>JP</given-names></name><name><surname>Zeng</surname><given-names>C</given-names></name><name><surname>Carlin</surname><given-names>C</given-names></name><name><surname>Lozanski</surname><given-names>G</given-names></name><name><surname>Saif</surname><given-names>LJ</given-names></name><name><surname>Oltz</surname><given-names>EM</given-names></name><name><surname>Gumina</surname><given-names>RJ</given-names></name><name><surname>Liu</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Neutralizing antibody responses elicited by SARS-Cov-2 mRNA vaccination wane over time and are boosted by breakthrough infection</article-title><source>Science Translational Medicine</source><volume>14</volume><elocation-id>eabn8057</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abn8057</pub-id><pub-id pub-id-type="pmid">35166573</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Files</surname><given-names>JK</given-names></name><name><surname>Boppana</surname><given-names>S</given-names></name><name><surname>Perez</surname><given-names>MD</given-names></name><name><surname>Sarkar</surname><given-names>S</given-names></name><name><surname>Lowman</surname><given-names>KE</given-names></name><name><surname>Qin</surname><given-names>K</given-names></name><name><surname>Sterrett</surname><given-names>S</given-names></name><name><surname>Carlin</surname><given-names>E</given-names></name><name><surname>Bansal</surname><given-names>A</given-names></name><name><surname>Sabbaj</surname><given-names>S</given-names></name><name><surname>Long</surname><given-names>DM</given-names></name><name><surname>Kutsch</surname><given-names>O</given-names></name><name><surname>Kobie</surname><given-names>J</given-names></name><name><surname>Goepfert</surname><given-names>PA</given-names></name><name><surname>Erdmann</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Sustained cellular immune dysregulation in individuals recovering from sars-cov-2 infection</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>e140491</elocation-id><pub-id pub-id-type="doi">10.1172/JCI140491</pub-id><pub-id pub-id-type="pmid">33119547</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaebler</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Lorenzi</surname><given-names>JCC</given-names></name><name><surname>Muecksch</surname><given-names>F</given-names></name><name><surname>Finkin</surname><given-names>S</given-names></name><name><surname>Tokuyama</surname><given-names>M</given-names></name><name><surname>Cho</surname><given-names>A</given-names></name><name><surname>Jankovic</surname><given-names>M</given-names></name><name><surname>Schaefer-Babajew</surname><given-names>D</given-names></name><name><surname>Oliveira</surname><given-names>TY</given-names></name><name><surname>Cipolla</surname><given-names>M</given-names></name><name><surname>Viant</surname><given-names>C</given-names></name><name><surname>Barnes</surname><given-names>CO</given-names></name><name><surname>Bram</surname><given-names>Y</given-names></name><name><surname>Breton</surname><given-names>G</given-names></name><name><surname>Hägglöf</surname><given-names>T</given-names></name><name><surname>Mendoza</surname><given-names>P</given-names></name><name><surname>Hurley</surname><given-names>A</given-names></name><name><surname>Turroja</surname><given-names>M</given-names></name><name><surname>Gordon</surname><given-names>K</given-names></name><name><surname>Millard</surname><given-names>KG</given-names></name><name><surname>Ramos</surname><given-names>V</given-names></name><name><surname>Schmidt</surname><given-names>F</given-names></name><name><surname>Weisblum</surname><given-names>Y</given-names></name><name><surname>Jha</surname><given-names>D</given-names></name><name><surname>Tankelevich</surname><given-names>M</given-names></name><name><surname>Martinez-Delgado</surname><given-names>G</given-names></name><name><surname>Yee</surname><given-names>J</given-names></name><name><surname>Patel</surname><given-names>R</given-names></name><name><surname>Dizon</surname><given-names>J</given-names></name><name><surname>Unson-O’Brien</surname><given-names>C</given-names></name><name><surname>Shimeliovich</surname><given-names>I</given-names></name><name><surname>Robbiani</surname><given-names>DF</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Gazumyan</surname><given-names>A</given-names></name><name><surname>Schwartz</surname><given-names>RE</given-names></name><name><surname>Hatziioannou</surname><given-names>T</given-names></name><name><surname>Bjorkman</surname><given-names>PJ</given-names></name><name><surname>Mehandru</surname><given-names>S</given-names></name><name><surname>Bieniasz</surname><given-names>PD</given-names></name><name><surname>Caskey</surname><given-names>M</given-names></name><name><surname>Nussenzweig</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Evolution of antibody immunity to SARS-Cov-2</article-title><source>Nature</source><volume>591</volume><fpage>639</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03207-w</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>JE</given-names></name><name><surname>Okyay</surname><given-names>RA</given-names></name><name><surname>Licht</surname><given-names>WE</given-names></name><name><surname>Hurley</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation</article-title><source>Pathogens</source><volume>10</volume><elocation-id>763</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens10060763</pub-id><pub-id pub-id-type="pmid">34204243</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhong</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Ren</surname><given-names>L</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Fan</surname><given-names>G</given-names></name><name><surname>Zou</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>Q</given-names></name><name><surname>Cao</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cross-reactive antibody against human Coronavirus Oc43 spike protein correlates with disease severity in COVID-19 patients: A retrospective study</article-title><source>Emerging Microbes &amp; Infections</source><volume>10</volume><fpage>664</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1080/22221751.2021.1905488</pub-id><pub-id pub-id-type="pmid">33734013</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Madhavan</surname><given-names>MV</given-names></name><name><surname>Sehgal</surname><given-names>K</given-names></name><name><surname>Nair</surname><given-names>N</given-names></name><name><surname>Mahajan</surname><given-names>S</given-names></name><name><surname>Sehrawat</surname><given-names>TS</given-names></name><name><surname>Bikdeli</surname><given-names>B</given-names></name><name><surname>Ahluwalia</surname><given-names>N</given-names></name><name><surname>Ausiello</surname><given-names>JC</given-names></name><name><surname>Wan</surname><given-names>EY</given-names></name><name><surname>Freedberg</surname><given-names>DE</given-names></name><name><surname>Kirtane</surname><given-names>AJ</given-names></name><name><surname>Parikh</surname><given-names>SA</given-names></name><name><surname>Maurer</surname><given-names>MS</given-names></name><name><surname>Nordvig</surname><given-names>AS</given-names></name><name><surname>Accili</surname><given-names>D</given-names></name><name><surname>Bathon</surname><given-names>JM</given-names></name><name><surname>Mohan</surname><given-names>S</given-names></name><name><surname>Bauer</surname><given-names>KA</given-names></name><name><surname>Leon</surname><given-names>MB</given-names></name><name><surname>Krumholz</surname><given-names>HM</given-names></name><name><surname>Uriel</surname><given-names>N</given-names></name><name><surname>Mehra</surname><given-names>MR</given-names></name><name><surname>Elkind</surname><given-names>MSV</given-names></name><name><surname>Stone</surname><given-names>GW</given-names></name><name><surname>Schwartz</surname><given-names>A</given-names></name><name><surname>Ho</surname><given-names>DD</given-names></name><name><surname>Bilezikian</surname><given-names>JP</given-names></name><name><surname>Landry</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Extrapulmonary manifestations of COVID-19</article-title><source>Nature Medicine</source><volume>26</volume><fpage>1017</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-0968-3</pub-id><pub-id pub-id-type="pmid">32651579</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Mao</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zuo</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Yen</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A novel method for food market regulation by emotional tendencies predictions from food reviews based on Blockchain and Saes</article-title><source>Foods</source><volume>10</volume><elocation-id>1398</elocation-id><pub-id pub-id-type="doi">10.3390/foods10061398</pub-id><pub-id pub-id-type="pmid">34204245</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Positive Epstein-Barr virus detection and mortality in respiratory failure patients admitted to the intensive care unit</article-title><source>The Clinical Respiratory Journal</source><volume>11</volume><fpage>895</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.1111/crj.12433</pub-id><pub-id pub-id-type="pmid">26663042</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>M</given-names></name><name><surname>Kleine-Weber</surname><given-names>H</given-names></name><name><surname>Schroeder</surname><given-names>S</given-names></name><name><surname>Krüger</surname><given-names>N</given-names></name><name><surname>Herrler</surname><given-names>T</given-names></name><name><surname>Erichsen</surname><given-names>S</given-names></name><name><surname>Schiergens</surname><given-names>TS</given-names></name><name><surname>Herrler</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>N-H</given-names></name><name><surname>Nitsche</surname><given-names>A</given-names></name><name><surname>Müller</surname><given-names>MA</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>Pöhlmann</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-Cov-2 cell entry depends on Ace2 and Tmprss2 and is blocked by a clinically proven protease inhibitor</article-title><source>Cell</source><volume>181</volume><fpage>271</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.02.052</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibarrondo</surname><given-names>FJ</given-names></name><name><surname>Fulcher</surname><given-names>JA</given-names></name><name><surname>Goodman-Meza</surname><given-names>D</given-names></name><name><surname>Elliott</surname><given-names>J</given-names></name><name><surname>Hofmann</surname><given-names>C</given-names></name><name><surname>Hausner</surname><given-names>MA</given-names></name><name><surname>Ferbas</surname><given-names>KG</given-names></name><name><surname>Tobin</surname><given-names>NH</given-names></name><name><surname>Aldrovandi</surname><given-names>GM</given-names></name><name><surname>Yang</surname><given-names>OO</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Rapid decay of anti-SARS-Cov-2 antibodies in persons with mild COVID-19</article-title><source>New England Journal of Medicine</source><volume>383</volume><fpage>1085</fpage><lpage>1087</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2025179</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarjour</surname><given-names>NN</given-names></name><name><surname>Masopust</surname><given-names>D</given-names></name><name><surname>Jameson</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>T cell memory: Understanding COVID-19</article-title><source>Immunity</source><volume>54</volume><fpage>14</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.12.009</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplonek</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Bartsch</surname><given-names>Y</given-names></name><name><surname>Fischinger</surname><given-names>S</given-names></name><name><surname>Gorman</surname><given-names>MJ</given-names></name><name><surname>Bowman</surname><given-names>K</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Dayal</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>P</given-names></name><name><surname>Nowak</surname><given-names>RP</given-names></name><name><surname>Villani</surname><given-names>A-C</given-names></name><name><surname>Hsieh</surname><given-names>C-L</given-names></name><name><surname>Charland</surname><given-names>NC</given-names></name><name><surname>Gonye</surname><given-names>ALK</given-names></name><name><surname>Gushterova</surname><given-names>I</given-names></name><name><surname>Khanna</surname><given-names>HK</given-names></name><name><surname>LaSalle</surname><given-names>TJ</given-names></name><name><surname>Lavin-Parsons</surname><given-names>KM</given-names></name><name><surname>Lilley</surname><given-names>BM</given-names></name><name><surname>Lodenstein</surname><given-names>CL</given-names></name><name><surname>Manakongtreecheep</surname><given-names>K</given-names></name><name><surname>Margolin</surname><given-names>JD</given-names></name><name><surname>McKaig</surname><given-names>BN</given-names></name><name><surname>Rojas-Lopez</surname><given-names>M</given-names></name><name><surname>Russo</surname><given-names>BC</given-names></name><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Tantivit</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>MF</given-names></name><name><surname>Sade-Feldman</surname><given-names>M</given-names></name><name><surname>Feldman</surname><given-names>J</given-names></name><name><surname>Julg</surname><given-names>B</given-names></name><name><surname>Nilles</surname><given-names>EJ</given-names></name><name><surname>Musk</surname><given-names>ER</given-names></name><name><surname>Menon</surname><given-names>AS</given-names></name><name><surname>Fischer</surname><given-names>ES</given-names></name><name><surname>McLellan</surname><given-names>JS</given-names></name><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Goldberg</surname><given-names>MB</given-names></name><name><surname>Filbin</surname><given-names>MR</given-names></name><name><surname>Hacohen</surname><given-names>N</given-names></name><name><surname>Lauffenburger</surname><given-names>DA</given-names></name><name><surname>Alter</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Early cross-Coronavirus reactive signatures of humoral immunity against COVID-19</article-title><source>Science Immunology</source><volume>6</volume><elocation-id>eabj2901</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.abj2901</pub-id><pub-id pub-id-type="pmid">34652962</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keita</surname><given-names>AK</given-names></name><name><surname>Vidal</surname><given-names>N</given-names></name><name><surname>Toure</surname><given-names>A</given-names></name><name><surname>Diallo</surname><given-names>MSK</given-names></name><name><surname>Magassouba</surname><given-names>N</given-names></name><name><surname>Baize</surname><given-names>S</given-names></name><name><surname>Mateo</surname><given-names>M</given-names></name><name><surname>Raoul</surname><given-names>H</given-names></name><name><surname>Mely</surname><given-names>S</given-names></name><name><surname>Subtil</surname><given-names>F</given-names></name><name><surname>Kpamou</surname><given-names>C</given-names></name><name><surname>Koivogui</surname><given-names>L</given-names></name><name><surname>Traore</surname><given-names>F</given-names></name><name><surname>Sow</surname><given-names>MS</given-names></name><name><surname>Ayouba</surname><given-names>A</given-names></name><name><surname>Etard</surname><given-names>JF</given-names></name><name><surname>Delaporte</surname><given-names>E</given-names></name><name><surname>Peeters</surname><given-names>M</given-names></name><collab>PostEbogui Study Group</collab></person-group><year iso-8601-date="2019">2019</year><article-title>A 40-month follow-up of Ebola virus disease survivors in Guinea (Postebogui) reveals long-term detection of Ebola viral ribonucleic acid in Semen and breast milk</article-title><source>Open Forum Infectious Diseases</source><volume>6</volume><elocation-id>fz482</elocation-id><pub-id pub-id-type="doi">10.1093/ofid/ofz482</pub-id><pub-id pub-id-type="pmid">32128327</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keita</surname><given-names>AK</given-names></name><name><surname>Koundouno</surname><given-names>FR</given-names></name><name><surname>Faye</surname><given-names>M</given-names></name><name><surname>Düx</surname><given-names>A</given-names></name><name><surname>Hinzmann</surname><given-names>J</given-names></name><name><surname>Diallo</surname><given-names>H</given-names></name><name><surname>Ayouba</surname><given-names>A</given-names></name><name><surname>Le Marcis</surname><given-names>F</given-names></name><name><surname>Soropogui</surname><given-names>B</given-names></name><name><surname>Ifono</surname><given-names>K</given-names></name><name><surname>Diagne</surname><given-names>MM</given-names></name><name><surname>Sow</surname><given-names>MS</given-names></name><name><surname>Bore</surname><given-names>JA</given-names></name><name><surname>Calvignac-Spencer</surname><given-names>S</given-names></name><name><surname>Vidal</surname><given-names>N</given-names></name><name><surname>Camara</surname><given-names>J</given-names></name><name><surname>Keita</surname><given-names>MB</given-names></name><name><surname>Renevey</surname><given-names>A</given-names></name><name><surname>Diallo</surname><given-names>A</given-names></name><name><surname>Soumah</surname><given-names>AK</given-names></name><name><surname>Millimono</surname><given-names>SL</given-names></name><name><surname>Mari-Saez</surname><given-names>A</given-names></name><name><surname>Diop</surname><given-names>M</given-names></name><name><surname>Doré</surname><given-names>A</given-names></name><name><surname>Soumah</surname><given-names>FY</given-names></name><name><surname>Kourouma</surname><given-names>K</given-names></name><name><surname>Vielle</surname><given-names>NJ</given-names></name><name><surname>Loucoubar</surname><given-names>C</given-names></name><name><surname>Camara</surname><given-names>I</given-names></name><name><surname>Kourouma</surname><given-names>K</given-names></name><name><surname>Annibaldis</surname><given-names>G</given-names></name><name><surname>Bah</surname><given-names>A</given-names></name><name><surname>Thielebein</surname><given-names>A</given-names></name><name><surname>Pahlmann</surname><given-names>M</given-names></name><name><surname>Pullan</surname><given-names>ST</given-names></name><name><surname>Carroll</surname><given-names>MW</given-names></name><name><surname>Quick</surname><given-names>J</given-names></name><name><surname>Formenty</surname><given-names>P</given-names></name><name><surname>Legand</surname><given-names>A</given-names></name><name><surname>Pietro</surname><given-names>K</given-names></name><name><surname>Wiley</surname><given-names>MR</given-names></name><name><surname>Tordo</surname><given-names>N</given-names></name><name><surname>Peyrefitte</surname><given-names>C</given-names></name><name><surname>McCrone</surname><given-names>JT</given-names></name><name><surname>Rambaut</surname><given-names>A</given-names></name><name><surname>Sidibé</surname><given-names>Y</given-names></name><name><surname>Barry</surname><given-names>MD</given-names></name><name><surname>Kourouma</surname><given-names>M</given-names></name><name><surname>Saouromou</surname><given-names>CD</given-names></name><name><surname>Condé</surname><given-names>M</given-names></name><name><surname>Baldé</surname><given-names>M</given-names></name><name><surname>Povogui</surname><given-names>M</given-names></name><name><surname>Keita</surname><given-names>S</given-names></name><name><surname>Diakite</surname><given-names>M</given-names></name><name><surname>Bah</surname><given-names>MS</given-names></name><name><surname>Sidibe</surname><given-names>A</given-names></name><name><surname>Diakite</surname><given-names>D</given-names></name><name><surname>Sako</surname><given-names>FB</given-names></name><name><surname>Traore</surname><given-names>FA</given-names></name><name><surname>Ki-Zerbo</surname><given-names>GA</given-names></name><name><surname>Lemey</surname><given-names>P</given-names></name><name><surname>Günther</surname><given-names>S</given-names></name><name><surname>Kafetzopoulou</surname><given-names>LE</given-names></name><name><surname>Sall</surname><given-names>AA</given-names></name><name><surname>Delaporte</surname><given-names>E</given-names></name><name><surname>Duraffour</surname><given-names>S</given-names></name><name><surname>Faye</surname><given-names>O</given-names></name><name><surname>Leendertz</surname><given-names>FH</given-names></name><name><surname>Peeters</surname><given-names>M</given-names></name><name><surname>Toure</surname><given-names>A</given-names></name><name><surname>Magassouba</surname><given-names>NF</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks</article-title><source>Nature</source><volume>597</volume><fpage>539</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03901-9</pub-id><pub-id pub-id-type="pmid">34526718</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HW</given-names></name><name><surname>Canchola</surname><given-names>JG</given-names></name><name><surname>Brandt</surname><given-names>CD</given-names></name><name><surname>Pyles</surname><given-names>G</given-names></name><name><surname>Chanock</surname><given-names>RM</given-names></name><name><surname>Jensen</surname><given-names>K</given-names></name><name><surname>Parrott</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="1969">1969</year><article-title>Respiratory syncytial virus disease in infants despite prior administration of Antigenic Inactivated vaccine</article-title><source>American Journal of Epidemiology</source><volume>89</volume><fpage>422</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a120955</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komaroff</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Is human Herpesvirus-6 a trigger for chronic fatigue syndrome</article-title><source>Journal of Clinical Virology</source><volume>37 Suppl 1</volume><fpage>S39</fpage><lpage>S46</lpage><pub-id pub-id-type="doi">10.1016/S1386-6532(06)70010-5</pub-id><pub-id pub-id-type="pmid">17276367</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>WS</given-names></name><name><surname>Wheatley</surname><given-names>AK</given-names></name><name><surname>Kent</surname><given-names>SJ</given-names></name><name><surname>DeKosky</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Antibody-dependent Enhancement and SARS-Cov-2 vaccines and therapies</article-title><source>Nature Microbiology</source><volume>5</volume><fpage>1185</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1038/s41564-020-00789-5</pub-id><pub-id pub-id-type="pmid">32908214</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehner</surname><given-names>GF</given-names></name><name><surname>Klein</surname><given-names>SJ</given-names></name><name><surname>Zoller</surname><given-names>H</given-names></name><name><surname>Peer</surname><given-names>A</given-names></name><name><surname>Bellmann</surname><given-names>R</given-names></name><name><surname>Joannidis</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Correlation of Interleukin-6 with Epstein-Barr virus levels in COVID-19</article-title><source>Critical Care</source><volume>24</volume><elocation-id>657</elocation-id><pub-id pub-id-type="doi">10.1186/s13054-020-03384-6</pub-id><pub-id pub-id-type="pmid">33228750</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>LI</given-names></name><name><surname>Munger</surname><given-names>KL</given-names></name><name><surname>Rubertone</surname><given-names>MV</given-names></name><name><surname>Peck</surname><given-names>CA</given-names></name><name><surname>Lennette</surname><given-names>ET</given-names></name><name><surname>Spiegelman</surname><given-names>D</given-names></name><name><surname>Ascherio</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis</article-title><source>JAMA</source><volume>293</volume><fpage>2496</fpage><lpage>2500</lpage><pub-id pub-id-type="doi">10.1001/jama.293.20.2496</pub-id><pub-id pub-id-type="pmid">15914750</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>EG</given-names></name><name><surname>Lustig</surname><given-names>Y</given-names></name><name><surname>Cohen</surname><given-names>C</given-names></name><name><surname>Fluss</surname><given-names>R</given-names></name><name><surname>Indenbaum</surname><given-names>V</given-names></name><name><surname>Amit</surname><given-names>S</given-names></name><name><surname>Doolman</surname><given-names>R</given-names></name><name><surname>Asraf</surname><given-names>K</given-names></name><name><surname>Mendelson</surname><given-names>E</given-names></name><name><surname>Ziv</surname><given-names>A</given-names></name><name><surname>Rubin</surname><given-names>C</given-names></name><name><surname>Freedman</surname><given-names>L</given-names></name><name><surname>Kreiss</surname><given-names>Y</given-names></name><name><surname>Regev-Yochay</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Waning immune humoral response to BNT162b2 COVID-19 vaccine over 6 months</article-title><source>New England Journal of Medicine</source><volume>385</volume><elocation-id>e84</elocation-id><pub-id pub-id-type="doi">10.1056/NEJMoa2114583</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Littlefield</surname><given-names>KM</given-names></name><name><surname>Watson</surname><given-names>RO</given-names></name><name><surname>Schneider</surname><given-names>JM</given-names></name><name><surname>Neff</surname><given-names>CP</given-names></name><name><surname>Yamada</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Campbell</surname><given-names>TB</given-names></name><name><surname>Falta</surname><given-names>MT</given-names></name><name><surname>Jolley</surname><given-names>SE</given-names></name><name><surname>Fontenot</surname><given-names>AP</given-names></name><name><surname>Palmer</surname><given-names>BE</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>SARS-Cov-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute Sequalae of SARS-Cov-2</article-title><source>PLOS Pathogens</source><volume>18</volume><elocation-id>e1010359</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1010359</pub-id><pub-id pub-id-type="pmid">35617421</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>WD</given-names></name><name><surname>Chang</surname><given-names>SY</given-names></name><name><surname>Wang</surname><given-names>JT</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name><name><surname>Hung</surname><given-names>CC</given-names></name><name><surname>Hsu</surname><given-names>CL</given-names></name><name><surname>Chang</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Prolonged virus shedding even after seroconversion in a patient with COVID-19</article-title><source>The Journal of Infection</source><volume>81</volume><fpage>318</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2020.03.063</pub-id><pub-id pub-id-type="pmid">32283147</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>TQ</given-names></name><name><surname>Marston</surname><given-names>BJ</given-names></name><name><surname>Dahl</surname><given-names>BA</given-names></name><name><surname>De Cock</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ebola: Anatomy of an epidemic</article-title><source>Annual Review of Medicine</source><volume>68</volume><fpage>359</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1146/annurev-med-052915-015604</pub-id><pub-id pub-id-type="pmid">27813879</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>W</given-names></name><name><surname>Pang</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Lai</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Su</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Baniyash</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Ling</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>Q</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Dynamics of TCR repertoire and T cell function in COVID-19 Convalescent individuals</article-title><source>Cell Discovery</source><volume>7</volume><elocation-id>89</elocation-id><pub-id pub-id-type="doi">10.1038/s41421-021-00321-x</pub-id><pub-id pub-id-type="pmid">34580278</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matschke</surname><given-names>J</given-names></name><name><surname>Lütgehetmann</surname><given-names>M</given-names></name><name><surname>Hagel</surname><given-names>C</given-names></name><name><surname>Sperhake</surname><given-names>JP</given-names></name><name><surname>Schröder</surname><given-names>AS</given-names></name><name><surname>Edler</surname><given-names>C</given-names></name><name><surname>Mushumba</surname><given-names>H</given-names></name><name><surname>Fitzek</surname><given-names>A</given-names></name><name><surname>Allweiss</surname><given-names>L</given-names></name><name><surname>Dandri</surname><given-names>M</given-names></name><name><surname>Dottermusch</surname><given-names>M</given-names></name><name><surname>Heinemann</surname><given-names>A</given-names></name><name><surname>Pfefferle</surname><given-names>S</given-names></name><name><surname>Schwabenland</surname><given-names>M</given-names></name><name><surname>Sumner Magruder</surname><given-names>D</given-names></name><name><surname>Bonn</surname><given-names>S</given-names></name><name><surname>Prinz</surname><given-names>M</given-names></name><name><surname>Gerloff</surname><given-names>C</given-names></name><name><surname>Püschel</surname><given-names>K</given-names></name><name><surname>Krasemann</surname><given-names>S</given-names></name><name><surname>Aepfelbacher</surname><given-names>M</given-names></name><name><surname>Glatzel</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Neuropathology of patients with COVID-19 in Germany: A post-Mortem case series</article-title><source>The Lancet. Neurology</source><volume>19</volume><fpage>919</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(20)30308-2</pub-id><pub-id pub-id-type="pmid">33031735</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meinhardt</surname><given-names>J</given-names></name><name><surname>Radke</surname><given-names>J</given-names></name><name><surname>Dittmayer</surname><given-names>C</given-names></name><name><surname>Franz</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>C</given-names></name><name><surname>Mothes</surname><given-names>R</given-names></name><name><surname>Laue</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>J</given-names></name><name><surname>Brünink</surname><given-names>S</given-names></name><name><surname>Greuel</surname><given-names>S</given-names></name><name><surname>Lehmann</surname><given-names>M</given-names></name><name><surname>Hassan</surname><given-names>O</given-names></name><name><surname>Aschman</surname><given-names>T</given-names></name><name><surname>Schumann</surname><given-names>E</given-names></name><name><surname>Chua</surname><given-names>RL</given-names></name><name><surname>Conrad</surname><given-names>C</given-names></name><name><surname>Eils</surname><given-names>R</given-names></name><name><surname>Stenzel</surname><given-names>W</given-names></name><name><surname>Windgassen</surname><given-names>M</given-names></name><name><surname>Rößler</surname><given-names>L</given-names></name><name><surname>Goebel</surname><given-names>H-H</given-names></name><name><surname>Gelderblom</surname><given-names>HR</given-names></name><name><surname>Martin</surname><given-names>H</given-names></name><name><surname>Nitsche</surname><given-names>A</given-names></name><name><surname>Schulz-Schaeffer</surname><given-names>WJ</given-names></name><name><surname>Hakroush</surname><given-names>S</given-names></name><name><surname>Winkler</surname><given-names>MS</given-names></name><name><surname>Tampe</surname><given-names>B</given-names></name><name><surname>Scheibe</surname><given-names>F</given-names></name><name><surname>Körtvélyessy</surname><given-names>P</given-names></name><name><surname>Reinhold</surname><given-names>D</given-names></name><name><surname>Siegmund</surname><given-names>B</given-names></name><name><surname>Kühl</surname><given-names>AA</given-names></name><name><surname>Elezkurtaj</surname><given-names>S</given-names></name><name><surname>Horst</surname><given-names>D</given-names></name><name><surname>Oesterhelweg</surname><given-names>L</given-names></name><name><surname>Tsokos</surname><given-names>M</given-names></name><name><surname>Ingold-Heppner</surname><given-names>B</given-names></name><name><surname>Stadelmann</surname><given-names>C</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>Corman</surname><given-names>VM</given-names></name><name><surname>Radbruch</surname><given-names>H</given-names></name><name><surname>Heppner</surname><given-names>FL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Olfactory Transmucosal SARS-Cov-2 invasion as a port of central nervous system entry in individuals with COVID-19</article-title><source>Nature Neuroscience</source><volume>24</volume><fpage>168</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-00758-5</pub-id><pub-id pub-id-type="pmid">33257876</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melms</surname><given-names>JC</given-names></name><name><surname>Biermann</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Nair</surname><given-names>A</given-names></name><name><surname>Tagore</surname><given-names>S</given-names></name><name><surname>Katsyv</surname><given-names>I</given-names></name><name><surname>Rendeiro</surname><given-names>AF</given-names></name><name><surname>Amin</surname><given-names>AD</given-names></name><name><surname>Schapiro</surname><given-names>D</given-names></name><name><surname>Frangieh</surname><given-names>CJ</given-names></name><name><surname>Luoma</surname><given-names>AM</given-names></name><name><surname>Filliol</surname><given-names>A</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Ravichandran</surname><given-names>H</given-names></name><name><surname>Clausi</surname><given-names>MG</given-names></name><name><surname>Alba</surname><given-names>GA</given-names></name><name><surname>Rogava</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>SW</given-names></name><name><surname>Ho</surname><given-names>P</given-names></name><name><surname>Montoro</surname><given-names>DT</given-names></name><name><surname>Kornberg</surname><given-names>AE</given-names></name><name><surname>Han</surname><given-names>AS</given-names></name><name><surname>Bakhoum</surname><given-names>MF</given-names></name><name><surname>Anandasabapathy</surname><given-names>N</given-names></name><name><surname>Suárez-Fariñas</surname><given-names>M</given-names></name><name><surname>Bakhoum</surname><given-names>SF</given-names></name><name><surname>Bram</surname><given-names>Y</given-names></name><name><surname>Borczuk</surname><given-names>A</given-names></name><name><surname>Guo</surname><given-names>XV</given-names></name><name><surname>Lefkowitch</surname><given-names>JH</given-names></name><name><surname>Marboe</surname><given-names>C</given-names></name><name><surname>Lagana</surname><given-names>SM</given-names></name><name><surname>Del Portillo</surname><given-names>A</given-names></name><name><surname>Tsai</surname><given-names>EJ</given-names></name><name><surname>Zorn</surname><given-names>E</given-names></name><name><surname>Markowitz</surname><given-names>GS</given-names></name><name><surname>Schwabe</surname><given-names>RF</given-names></name><name><surname>Schwartz</surname><given-names>RE</given-names></name><name><surname>Elemento</surname><given-names>O</given-names></name><name><surname>Saqi</surname><given-names>A</given-names></name><name><surname>Hibshoosh</surname><given-names>H</given-names></name><name><surname>Que</surname><given-names>J</given-names></name><name><surname>Izar</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A molecular single-cell lung Atlas of lethal COVID-19</article-title><source>Nature</source><volume>598</volume><fpage>114</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03921-5</pub-id><pub-id pub-id-type="pmid">34625743</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>KW</given-names></name><name><surname>Faulkner</surname><given-names>N</given-names></name><name><surname>Cornish</surname><given-names>GH</given-names></name><name><surname>Rosa</surname><given-names>A</given-names></name><name><surname>Harvey</surname><given-names>R</given-names></name><name><surname>Hussain</surname><given-names>S</given-names></name><name><surname>Ulferts</surname><given-names>R</given-names></name><name><surname>Earl</surname><given-names>C</given-names></name><name><surname>Wrobel</surname><given-names>AG</given-names></name><name><surname>Benton</surname><given-names>DJ</given-names></name><name><surname>Roustan</surname><given-names>C</given-names></name><name><surname>Bolland</surname><given-names>W</given-names></name><name><surname>Thompson</surname><given-names>R</given-names></name><name><surname>Agua-Doce</surname><given-names>A</given-names></name><name><surname>Hobson</surname><given-names>P</given-names></name><name><surname>Heaney</surname><given-names>J</given-names></name><name><surname>Rickman</surname><given-names>H</given-names></name><name><surname>Paraskevopoulou</surname><given-names>S</given-names></name><name><surname>Houlihan</surname><given-names>CF</given-names></name><name><surname>Thomson</surname><given-names>K</given-names></name><name><surname>Sanchez</surname><given-names>E</given-names></name><name><surname>Shin</surname><given-names>GY</given-names></name><name><surname>Spyer</surname><given-names>MJ</given-names></name><name><surname>Joshi</surname><given-names>D</given-names></name><name><surname>O’Reilly</surname><given-names>N</given-names></name><name><surname>Walker</surname><given-names>PA</given-names></name><name><surname>Kjaer</surname><given-names>S</given-names></name><name><surname>Riddell</surname><given-names>A</given-names></name><name><surname>Moore</surname><given-names>C</given-names></name><name><surname>Jebson</surname><given-names>BR</given-names></name><name><surname>Wilkinson</surname><given-names>M</given-names></name><name><surname>Marshall</surname><given-names>LR</given-names></name><name><surname>Rosser</surname><given-names>EC</given-names></name><name><surname>Radziszewska</surname><given-names>A</given-names></name><name><surname>Peckham</surname><given-names>H</given-names></name><name><surname>Ciurtin</surname><given-names>C</given-names></name><name><surname>Wedderburn</surname><given-names>LR</given-names></name><name><surname>Beale</surname><given-names>R</given-names></name><name><surname>Swanton</surname><given-names>C</given-names></name><name><surname>Gandhi</surname><given-names>S</given-names></name><name><surname>Stockinger</surname><given-names>B</given-names></name><name><surname>McCauley</surname><given-names>J</given-names></name><name><surname>Gamblin</surname><given-names>SJ</given-names></name><name><surname>McCoy</surname><given-names>LE</given-names></name><name><surname>Cherepanov</surname><given-names>P</given-names></name><name><surname>Nastouli</surname><given-names>E</given-names></name><name><surname>Kassiotis</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Preexisting and de novo humoral immunity to SARS-Cov-2 in humans</article-title><source>Science</source><volume>370</volume><fpage>1339</fpage><lpage>1343</lpage><pub-id pub-id-type="doi">10.1126/science.abe1107</pub-id><pub-id pub-id-type="pmid">33159009</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omololu</surname><given-names>A</given-names></name><name><surname>Ojelade</surname><given-names>B</given-names></name><name><surname>Ajayi</surname><given-names>O</given-names></name><name><surname>Adesomi</surname><given-names>T</given-names></name><name><surname>Alade</surname><given-names>O</given-names></name><name><surname>Adebisi</surname><given-names>S</given-names></name><name><surname>Nwadike</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>&quot;Long COVID&quot;: A case report of persistent symptoms in a patient with prolonged SARS-Cov-2 shedding for over 110 days</article-title><source>SAGE Open Medical Case Reports</source><volume>9</volume><elocation-id>2050313X211015494</elocation-id><pub-id pub-id-type="doi">10.1177/2050313X211015494</pub-id><pub-id pub-id-type="pmid">34035919</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>BK</given-names></name><name><surname>Francisco</surname><given-names>EB</given-names></name><name><surname>Yogendra</surname><given-names>R</given-names></name><name><surname>Long</surname><given-names>E</given-names></name><name><surname>Pise</surname><given-names>A</given-names></name><name><surname>Rodrigues</surname><given-names>H</given-names></name><name><surname>Hall</surname><given-names>E</given-names></name><name><surname>Herrera</surname><given-names>M</given-names></name><name><surname>Parikh</surname><given-names>P</given-names></name><name><surname>Guevara-Coto</surname><given-names>J</given-names></name><name><surname>Triche</surname><given-names>TJ</given-names></name><name><surname>Scott</surname><given-names>P</given-names></name><name><surname>Hekmati</surname><given-names>S</given-names></name><name><surname>Maglinte</surname><given-names>D</given-names></name><name><surname>Chang</surname><given-names>X</given-names></name><name><surname>Mora-Rodríguez</surname><given-names>RA</given-names></name><name><surname>Mora</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Persistence of SARS Cov-2 S1 protein in Cd16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection</article-title><source>Frontiers in Immunology</source><volume>12</volume><elocation-id>746021</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.746021</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peluso</surname><given-names>MJ</given-names></name><name><surname>Deitchman</surname><given-names>AN</given-names></name><name><surname>Torres</surname><given-names>L</given-names></name><name><surname>Iyer</surname><given-names>NS</given-names></name><name><surname>Munter</surname><given-names>SE</given-names></name><name><surname>Nixon</surname><given-names>CC</given-names></name><name><surname>Donatelli</surname><given-names>J</given-names></name><name><surname>Thanh</surname><given-names>C</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Hakim</surname><given-names>J</given-names></name><name><surname>Turcios</surname><given-names>K</given-names></name><name><surname>Janson</surname><given-names>O</given-names></name><name><surname>Hoh</surname><given-names>R</given-names></name><name><surname>Tai</surname><given-names>V</given-names></name><name><surname>Hernandez</surname><given-names>Y</given-names></name><name><surname>Fehrman</surname><given-names>EA</given-names></name><name><surname>Spinelli</surname><given-names>MA</given-names></name><name><surname>Gandhi</surname><given-names>M</given-names></name><name><surname>Trinh</surname><given-names>L</given-names></name><name><surname>Wrin</surname><given-names>T</given-names></name><name><surname>Petropoulos</surname><given-names>CJ</given-names></name><name><surname>Aweeka</surname><given-names>FT</given-names></name><name><surname>Rodriguez-Barraquer</surname><given-names>I</given-names></name><name><surname>Kelly</surname><given-names>JD</given-names></name><name><surname>Martin</surname><given-names>JN</given-names></name><name><surname>Deeks</surname><given-names>SG</given-names></name><name><surname>Greenhouse</surname><given-names>B</given-names></name><name><surname>Rutishauser</surname><given-names>RL</given-names></name><name><surname>Henrich</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Long-term SARS-Cov-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms</article-title><source>Cell Reports</source><volume>36</volume><elocation-id>109518</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109518</pub-id><pub-id pub-id-type="pmid">34358460</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>C</given-names></name><name><surname>Harris</surname><given-names>BHL</given-names></name><name><surname>Di Giovannantonio</surname><given-names>M</given-names></name><name><surname>Rosadas</surname><given-names>C</given-names></name><name><surname>Short</surname><given-names>C-E</given-names></name><name><surname>Quinlan</surname><given-names>R</given-names></name><name><surname>Sureda-Vives</surname><given-names>M</given-names></name><name><surname>Fernandez</surname><given-names>N</given-names></name><name><surname>Day-Weber</surname><given-names>I</given-names></name><name><surname>Khan</surname><given-names>M</given-names></name><name><surname>Marchesin</surname><given-names>F</given-names></name><name><surname>Katsanovskaja</surname><given-names>K</given-names></name><name><surname>Parker</surname><given-names>E</given-names></name><name><surname>Taylor</surname><given-names>GP</given-names></name><name><surname>Tedder</surname><given-names>RS</given-names></name><name><surname>McClure</surname><given-names>MO</given-names></name><name><surname>Dani</surname><given-names>M</given-names></name><name><surname>Fertleman</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The association between antibody response to severe acute respiratory syndrome Coronavirus 2 infection and post-COVID-19 syndrome in Healthcare workers</article-title><source>The Journal of Infectious Diseases</source><volume>223</volume><fpage>1671</fpage><lpage>1676</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiab120</pub-id><pub-id pub-id-type="pmid">33675366</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proal</surname><given-names>AD</given-names></name><name><surname>VanElzakker</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms</article-title><source>Frontiers in Microbiology</source><volume>12</volume><elocation-id>698169</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2021.698169</pub-id><pub-id pub-id-type="pmid">34248921</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puelles</surname><given-names>VG</given-names></name><name><surname>Lütgehetmann</surname><given-names>M</given-names></name><name><surname>Lindenmeyer</surname><given-names>MT</given-names></name><name><surname>Sperhake</surname><given-names>JP</given-names></name><name><surname>Wong</surname><given-names>MN</given-names></name><name><surname>Allweiss</surname><given-names>L</given-names></name><name><surname>Chilla</surname><given-names>S</given-names></name><name><surname>Heinemann</surname><given-names>A</given-names></name><name><surname>Wanner</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Braun</surname><given-names>F</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Pfefferle</surname><given-names>S</given-names></name><name><surname>Schröder</surname><given-names>AS</given-names></name><name><surname>Edler</surname><given-names>C</given-names></name><name><surname>Gross</surname><given-names>O</given-names></name><name><surname>Glatzel</surname><given-names>M</given-names></name><name><surname>Wichmann</surname><given-names>D</given-names></name><name><surname>Wiech</surname><given-names>T</given-names></name><name><surname>Kluge</surname><given-names>S</given-names></name><name><surname>Pueschel</surname><given-names>K</given-names></name><name><surname>Aepfelbacher</surname><given-names>M</given-names></name><name><surname>Huber</surname><given-names>TB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Multiorgan and renal Tropism of SARS-Cov-2</article-title><source>The New England Journal of Medicine</source><volume>383</volume><fpage>590</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2011400</pub-id><pub-id pub-id-type="pmid">32402155</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>F</given-names></name><name><surname>Qian</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human Coronaviruses</article-title><source>Biochemical and Biophysical Research Communications</source><volume>526</volume><fpage>135</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2020.03.044</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebman</surname><given-names>AW</given-names></name><name><surname>Aucott</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease</article-title><source>Frontiers in Medicine</source><volume>7</volume><elocation-id>57</elocation-id><pub-id pub-id-type="doi">10.3389/fmed.2020.00057</pub-id><pub-id pub-id-type="pmid">32161761</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Wen</surname><given-names>W</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Hou</surname><given-names>W</given-names></name><name><surname>Su</surname><given-names>B</given-names></name><name><surname>Cai</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Cao</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>G</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Ding</surname><given-names>W</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Gan</surname><given-names>R</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Ling</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>S-Q</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Song</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Xing</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Yin</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Zhong</surname><given-names>S</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>P</given-names></name><name><surname>Zou</surname><given-names>B</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Zuo</surname><given-names>Z</given-names></name><name><surname>Bai</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Jiang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Bei</surname><given-names>J-X</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Bian</surname><given-names>X-W</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>F-S</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Qu</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>COVID-19 immune features revealed by a large-scale single-cell Transcriptome Atlas</article-title><source>Cell</source><volume>184</volume><elocation-id>5838</elocation-id><pub-id pub-id-type="doi">10.1016/j.cell.2021.10.023</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>FJ</given-names></name><name><surname>Hope</surname><given-names>CM</given-names></name><name><surname>Masavuli</surname><given-names>MG</given-names></name><name><surname>Lynn</surname><given-names>MA</given-names></name><name><surname>Mekonnen</surname><given-names>ZA</given-names></name><name><surname>Yeow</surname><given-names>AEL</given-names></name><name><surname>Garcia-Valtanen</surname><given-names>P</given-names></name><name><surname>Al-Delfi</surname><given-names>Z</given-names></name><name><surname>Gummow</surname><given-names>J</given-names></name><name><surname>Ferguson</surname><given-names>C</given-names></name><name><surname>O’Connor</surname><given-names>S</given-names></name><name><surname>Reddi</surname><given-names>BAJ</given-names></name><name><surname>Hissaria</surname><given-names>P</given-names></name><name><surname>Shaw</surname><given-names>D</given-names></name><name><surname>Kok-Lim</surname><given-names>C</given-names></name><name><surname>Gleadle</surname><given-names>JM</given-names></name><name><surname>Beard</surname><given-names>MR</given-names></name><name><surname>Barry</surname><given-names>SC</given-names></name><name><surname>Grubor-Bauk</surname><given-names>B</given-names></name><name><surname>Lynn</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Long-term perturbation of the peripheral immune system months after SARS-Cov-2 infection</article-title><source>BMC Medicine</source><volume>20</volume><elocation-id>26</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-021-02228-6</pub-id><pub-id pub-id-type="pmid">35027067</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagar</surname><given-names>M</given-names></name><name><surname>Reifler</surname><given-names>K</given-names></name><name><surname>Rossi</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>NS</given-names></name><name><surname>Sinha</surname><given-names>P</given-names></name><name><surname>White</surname><given-names>LF</given-names></name><name><surname>Mizgerd</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Recent Endemic Coronavirus infection is associated with less-severe COVID-19</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>e143380</elocation-id><pub-id pub-id-type="doi">10.1172/JCI143380</pub-id><pub-id pub-id-type="pmid">32997649</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salou</surname><given-names>M</given-names></name><name><surname>Nicol</surname><given-names>B</given-names></name><name><surname>Garcia</surname><given-names>A</given-names></name><name><surname>Laplaud</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Involvement of Cd8(+) T cells in multiple sclerosis</article-title><source>Frontiers in Immunology</source><volume>6</volume><elocation-id>604</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2015.00604</pub-id><pub-id pub-id-type="pmid">26635816</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sausen</surname><given-names>DG</given-names></name><name><surname>Bhutta</surname><given-names>MS</given-names></name><name><surname>Gallo</surname><given-names>ES</given-names></name><name><surname>Dahari</surname><given-names>H</given-names></name><name><surname>Borenstein</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Stress-induced Epstein-Barr virus reactivation</article-title><source>Biomolecules</source><volume>11</volume><elocation-id>1380</elocation-id><pub-id pub-id-type="doi">10.3390/biom11091380</pub-id><pub-id pub-id-type="pmid">34572593</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seow</surname><given-names>J</given-names></name><name><surname>Graham</surname><given-names>C</given-names></name><name><surname>Merrick</surname><given-names>B</given-names></name><name><surname>Acors</surname><given-names>S</given-names></name><name><surname>Pickering</surname><given-names>S</given-names></name><name><surname>Steel</surname><given-names>KJA</given-names></name><name><surname>Hemmings</surname><given-names>O</given-names></name><name><surname>O’Byrne</surname><given-names>A</given-names></name><name><surname>Kouphou</surname><given-names>N</given-names></name><name><surname>Galao</surname><given-names>RP</given-names></name><name><surname>Betancor</surname><given-names>G</given-names></name><name><surname>Wilson</surname><given-names>HD</given-names></name><name><surname>Signell</surname><given-names>AW</given-names></name><name><surname>Winstone</surname><given-names>H</given-names></name><name><surname>Kerridge</surname><given-names>C</given-names></name><name><surname>Huettner</surname><given-names>I</given-names></name><name><surname>Jimenez-Guardeño</surname><given-names>JM</given-names></name><name><surname>Lista</surname><given-names>MJ</given-names></name><name><surname>Temperton</surname><given-names>N</given-names></name><name><surname>Snell</surname><given-names>LB</given-names></name><name><surname>Bisnauthsing</surname><given-names>K</given-names></name><name><surname>Moore</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>A</given-names></name><name><surname>Martinez</surname><given-names>L</given-names></name><name><surname>Stokes</surname><given-names>B</given-names></name><name><surname>Honey</surname><given-names>J</given-names></name><name><surname>Izquierdo-Barras</surname><given-names>A</given-names></name><name><surname>Arbane</surname><given-names>G</given-names></name><name><surname>Patel</surname><given-names>A</given-names></name><name><surname>Tan</surname><given-names>MKI</given-names></name><name><surname>O’Connell</surname><given-names>L</given-names></name><name><surname>O’Hara</surname><given-names>G</given-names></name><name><surname>MacMahon</surname><given-names>E</given-names></name><name><surname>Douthwaite</surname><given-names>S</given-names></name><name><surname>Nebbia</surname><given-names>G</given-names></name><name><surname>Batra</surname><given-names>R</given-names></name><name><surname>Martinez-Nunez</surname><given-names>R</given-names></name><name><surname>Shankar-Hari</surname><given-names>M</given-names></name><name><surname>Edgeworth</surname><given-names>JD</given-names></name><name><surname>Neil</surname><given-names>SJD</given-names></name><name><surname>Malim</surname><given-names>MH</given-names></name><name><surname>Doores</surname><given-names>KJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-Cov-2 infection in humans</article-title><source>Nature Microbiology</source><volume>5</volume><fpage>1598</fpage><lpage>1607</lpage><pub-id pub-id-type="doi">10.1038/s41564-020-00813-8</pub-id><pub-id pub-id-type="pmid">33106674</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>J</given-names></name><name><surname>Ye</surname><given-names>G</given-names></name><name><surname>Shi</surname><given-names>K</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>C</given-names></name><name><surname>Aihara</surname><given-names>H</given-names></name><name><surname>Geng</surname><given-names>Q</given-names></name><name><surname>Auerbach</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structural basis of receptor recognition by SARS-Cov-2</article-title><source>Nature</source><volume>581</volume><fpage>221</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2179-y</pub-id><pub-id pub-id-type="pmid">32225175</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharova</surname><given-names>LV</given-names></name><name><surname>Sharov</surname><given-names>AA</given-names></name><name><surname>Nedorezov</surname><given-names>T</given-names></name><name><surname>Piao</surname><given-names>Y</given-names></name><name><surname>Shaik</surname><given-names>N</given-names></name><name><surname>Ko</surname><given-names>MSH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Database for mRNA half-life of 19 977 genes obtained by DNA Microarray analysis of Pluripotent and differentiating mouse embryonic stem cells</article-title><source>DNA Research</source><volume>16</volume><fpage>45</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1093/dnares/dsn030</pub-id><pub-id pub-id-type="pmid">19001483</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simula</surname><given-names>ER</given-names></name><name><surname>Manca</surname><given-names>MA</given-names></name><name><surname>Noli</surname><given-names>M</given-names></name><name><surname>Jasemi</surname><given-names>S</given-names></name><name><surname>Ruberto</surname><given-names>S</given-names></name><name><surname>Uzzau</surname><given-names>S</given-names></name><name><surname>Rubino</surname><given-names>S</given-names></name><name><surname>Manca</surname><given-names>P</given-names></name><name><surname>Sechi</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Increased presence of antibodies against type I Interferons and human endogenous Retrovirus W in intensive care unit COVID-19 patients</article-title><source>Microbiology Spectrum</source><volume>10</volume><elocation-id>e0128022</elocation-id><pub-id pub-id-type="doi">10.1128/spectrum.01280-22</pub-id><pub-id pub-id-type="pmid">35852349</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Israelow</surname><given-names>B</given-names></name><name><surname>Lu-Culligan</surname><given-names>A</given-names></name><name><surname>Prado</surname><given-names>AV</given-names></name><name><surname>Skriabine</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>P</given-names></name><name><surname>Weizman</surname><given-names>O-E</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Szigeti-Buck</surname><given-names>K</given-names></name><name><surname>Yasumoto</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Castaldi</surname><given-names>C</given-names></name><name><surname>Heltke</surname><given-names>J</given-names></name><name><surname>Ng</surname><given-names>E</given-names></name><name><surname>Wheeler</surname><given-names>J</given-names></name><name><surname>Alfajaro</surname><given-names>MM</given-names></name><name><surname>Levavasseur</surname><given-names>E</given-names></name><name><surname>Fontes</surname><given-names>B</given-names></name><name><surname>Ravindra</surname><given-names>NG</given-names></name><name><surname>Van Dijk</surname><given-names>D</given-names></name><name><surname>Mane</surname><given-names>S</given-names></name><name><surname>Gunel</surname><given-names>M</given-names></name><name><surname>Ring</surname><given-names>A</given-names></name><name><surname>Kazmi</surname><given-names>SAJ</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Wilen</surname><given-names>CB</given-names></name><name><surname>Horvath</surname><given-names>TL</given-names></name><name><surname>Plu</surname><given-names>I</given-names></name><name><surname>Haik</surname><given-names>S</given-names></name><name><surname>Thomas</surname><given-names>J-L</given-names></name><name><surname>Louvi</surname><given-names>A</given-names></name><name><surname>Farhadian</surname><given-names>SF</given-names></name><name><surname>Huttner</surname><given-names>A</given-names></name><name><surname>Seilhean</surname><given-names>D</given-names></name><name><surname>Renier</surname><given-names>N</given-names></name><name><surname>Bilguvar</surname><given-names>K</given-names></name><name><surname>Iwasaki</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Neuroinvasion of SARS-Cov-2 in human and mouse brain</article-title><source>The Journal of Experimental Medicine</source><volume>218</volume><elocation-id>e20202135</elocation-id><pub-id pub-id-type="doi">10.1084/jem.20202135</pub-id><pub-id pub-id-type="pmid">33433624</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>DG</given-names></name><name><surname>Ng</surname><given-names>RH</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Hong</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Kornilov</surname><given-names>SA</given-names></name><name><surname>Scherler</surname><given-names>K</given-names></name><name><surname>Pavlovitch-Bedzyk</surname><given-names>AJ</given-names></name><name><surname>Dong</surname><given-names>S</given-names></name><name><surname>Lausted</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>I</given-names></name><name><surname>Fallen</surname><given-names>S</given-names></name><name><surname>Dai</surname><given-names>CL</given-names></name><name><surname>Baloni</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>B</given-names></name><name><surname>Duvvuri</surname><given-names>VR</given-names></name><name><surname>Anderson</surname><given-names>KG</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Duncombe</surname><given-names>CJ</given-names></name><name><surname>McCulloch</surname><given-names>DJ</given-names></name><name><surname>Rostomily</surname><given-names>C</given-names></name><name><surname>Troisch</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Mackay</surname><given-names>S</given-names></name><name><surname>DeGottardi</surname><given-names>Q</given-names></name><name><surname>May</surname><given-names>DH</given-names></name><name><surname>Taniguchi</surname><given-names>R</given-names></name><name><surname>Gittelman</surname><given-names>RM</given-names></name><name><surname>Klinger</surname><given-names>M</given-names></name><name><surname>Snyder</surname><given-names>TM</given-names></name><name><surname>Roper</surname><given-names>R</given-names></name><name><surname>Wojciechowska</surname><given-names>G</given-names></name><name><surname>Murray</surname><given-names>K</given-names></name><name><surname>Edmark</surname><given-names>R</given-names></name><name><surname>Evans</surname><given-names>S</given-names></name><name><surname>Jones</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Rowen</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Chour</surname><given-names>W</given-names></name><name><surname>Algren</surname><given-names>HA</given-names></name><name><surname>Berrington</surname><given-names>WR</given-names></name><name><surname>Wallick</surname><given-names>JA</given-names></name><name><surname>Cochran</surname><given-names>RA</given-names></name><name><surname>Micikas</surname><given-names>ME</given-names></name><name><surname>Wrin</surname><given-names>T</given-names></name><name><surname>Petropoulos</surname><given-names>CJ</given-names></name><name><surname>Cole</surname><given-names>HR</given-names></name><name><surname>Fischer</surname><given-names>TD</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Hoon</surname><given-names>DSB</given-names></name><name><surname>Price</surname><given-names>ND</given-names></name><name><surname>Subramanian</surname><given-names>N</given-names></name><name><surname>Hill</surname><given-names>JA</given-names></name><name><surname>Hadlock</surname><given-names>J</given-names></name><name><surname>Magis</surname><given-names>AT</given-names></name><name><surname>Ribas</surname><given-names>A</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name><name><surname>Boyd</surname><given-names>SD</given-names></name><name><surname>Bluestone</surname><given-names>JA</given-names></name><name><surname>Chu</surname><given-names>H</given-names></name><name><surname>Hood</surname><given-names>L</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name><name><surname>Greenberg</surname><given-names>PD</given-names></name><name><surname>Davis</surname><given-names>MM</given-names></name><name><surname>Goldman</surname><given-names>JD</given-names></name><name><surname>Heath</surname><given-names>JR</given-names></name><collab>ISB-Swedish COVID-19 Biobanking Unit</collab></person-group><year iso-8601-date="2022">2022</year><article-title>Multiple early factors anticipate post-acute COVID-19 sequelae</article-title><source>Cell</source><volume>185</volume><fpage>881</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.01.014</pub-id><pub-id pub-id-type="pmid">35216672</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sungnak</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Bécavin</surname><given-names>C</given-names></name><name><surname>Berg</surname><given-names>M</given-names></name><name><surname>Queen</surname><given-names>R</given-names></name><name><surname>Litvinukova</surname><given-names>M</given-names></name><name><surname>Talavera-López</surname><given-names>C</given-names></name><name><surname>Maatz</surname><given-names>H</given-names></name><name><surname>Reichart</surname><given-names>D</given-names></name><name><surname>Sampaziotis</surname><given-names>F</given-names></name><name><surname>Worlock</surname><given-names>KB</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Barnes</surname><given-names>JL</given-names></name><collab>HCA Lung Biological Network</collab></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-Cov-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes</article-title><source>Nature Medicine</source><volume>26</volume><fpage>681</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-0868-6</pub-id><pub-id pub-id-type="pmid">32327758</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swank</surname><given-names>Z</given-names></name><name><surname>Senussi</surname><given-names>Y</given-names></name><name><surname>Manickas-Hill</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>XG</given-names></name><name><surname>Li</surname><given-names>JZ</given-names></name><name><surname>Alter</surname><given-names>G</given-names></name><name><surname>Walt</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae</article-title><source>Clinical Infectious Diseases</source><volume>76</volume><fpage>e487</fpage><lpage>e490</lpage><pub-id pub-id-type="doi">10.1093/cid/ciac722</pub-id><pub-id pub-id-type="pmid">36052466</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>PH</given-names></name><name><surname>Ji</surname><given-names>J</given-names></name><name><surname>Hsing</surname><given-names>CH</given-names></name><name><surname>Tan</surname><given-names>R</given-names></name><name><surname>Ji</surname><given-names>RR</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Emerging roles of type-I Interferons in Neuroinflammation, neurological diseases, and long-haul COVID</article-title><source>International Journal of Molecular Sciences</source><volume>23</volume><elocation-id>14394</elocation-id><pub-id pub-id-type="doi">10.3390/ijms232214394</pub-id><pub-id pub-id-type="pmid">36430870</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tejerina</surname><given-names>F</given-names></name><name><surname>Catalan</surname><given-names>P</given-names></name><name><surname>Rodriguez-Grande</surname><given-names>C</given-names></name><name><surname>Adan</surname><given-names>J</given-names></name><name><surname>Rodriguez-Gonzalez</surname><given-names>C</given-names></name><name><surname>Muñoz</surname><given-names>P</given-names></name><name><surname>Aldamiz</surname><given-names>T</given-names></name><name><surname>Diez</surname><given-names>C</given-names></name><name><surname>Perez</surname><given-names>L</given-names></name><name><surname>Fanciulli</surname><given-names>C</given-names></name><name><surname>Garcia de Viedma</surname><given-names>D</given-names></name><collab>Gregorio Marañon Microbiology ID COVID 19 Study Group</collab></person-group><year iso-8601-date="2022">2022</year><article-title>Post-COVID-19 syndrome. SARS-Cov-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19</article-title><source>BMC Infectious Diseases</source><volume>22</volume><elocation-id>211</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-022-07153-4</pub-id><pub-id pub-id-type="pmid">35240997</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temerozo</surname><given-names>JR</given-names></name><name><surname>Fintelman-Rodrigues</surname><given-names>N</given-names></name><name><surname>Dos Santos</surname><given-names>MC</given-names></name><name><surname>Hottz</surname><given-names>ED</given-names></name><name><surname>Sacramento</surname><given-names>CQ</given-names></name><name><surname>de Paula Dias da Silva</surname><given-names>A</given-names></name><name><surname>Mandacaru</surname><given-names>SC</given-names></name><name><surname>Dos Santos Moraes</surname><given-names>EC</given-names></name><name><surname>Trugilho</surname><given-names>MRO</given-names></name><name><surname>Gesto</surname><given-names>JSM</given-names></name><name><surname>Ferreira</surname><given-names>MA</given-names></name><name><surname>Saraiva</surname><given-names>FB</given-names></name><name><surname>Palhinha</surname><given-names>L</given-names></name><name><surname>Martins-Gonçalves</surname><given-names>R</given-names></name><name><surname>Azevedo-Quintanilha</surname><given-names>IG</given-names></name><name><surname>Abrantes</surname><given-names>JL</given-names></name><name><surname>Righy</surname><given-names>C</given-names></name><name><surname>Kurtz</surname><given-names>P</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Tan</surname><given-names>H</given-names></name><name><surname>Morel</surname><given-names>C</given-names></name><name><surname>Bou-Habib</surname><given-names>DC</given-names></name><name><surname>Bozza</surname><given-names>FA</given-names></name><name><surname>Bozza</surname><given-names>PT</given-names></name><name><surname>Souza</surname><given-names>TML</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Human endogenous Retrovirus K in the respiratory tract is associated with COVID-19 Physiopathology</article-title><source>Microbiome</source><volume>10</volume><elocation-id>65</elocation-id><pub-id pub-id-type="doi">10.1186/s40168-022-01260-9</pub-id><pub-id pub-id-type="pmid">35459226</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tschöpe</surname><given-names>C</given-names></name><name><surname>Ammirati</surname><given-names>E</given-names></name><name><surname>Bozkurt</surname><given-names>B</given-names></name><name><surname>Caforio</surname><given-names>ALP</given-names></name><name><surname>Cooper</surname><given-names>LT</given-names></name><name><surname>Felix</surname><given-names>SB</given-names></name><name><surname>Hare</surname><given-names>JM</given-names></name><name><surname>Heidecker</surname><given-names>B</given-names></name><name><surname>Heymans</surname><given-names>S</given-names></name><name><surname>Hübner</surname><given-names>N</given-names></name><name><surname>Kelle</surname><given-names>S</given-names></name><name><surname>Klingel</surname><given-names>K</given-names></name><name><surname>Maatz</surname><given-names>H</given-names></name><name><surname>Parwani</surname><given-names>AS</given-names></name><name><surname>Spillmann</surname><given-names>F</given-names></name><name><surname>Starling</surname><given-names>RC</given-names></name><name><surname>Tsutsui</surname><given-names>H</given-names></name><name><surname>Seferovic</surname><given-names>P</given-names></name><name><surname>Van Linthout</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions</article-title><source>Nature Reviews. Cardiology</source><volume>18</volume><fpage>169</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1038/s41569-020-00435-x</pub-id><pub-id pub-id-type="pmid">33046850</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Nierop</surname><given-names>GP</given-names></name><name><surname>Mautner</surname><given-names>J</given-names></name><name><surname>Mitterreiter</surname><given-names>JG</given-names></name><name><surname>Hintzen</surname><given-names>RQ</given-names></name><name><surname>Verjans</surname><given-names>GMGM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Intrathecal Cd8 T-cells of multiple sclerosis patients recognize Lytic Epstein-Barr virus proteins</article-title><source>Multiple Sclerosis</source><volume>22</volume><fpage>279</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1177/1352458515588581</pub-id><pub-id pub-id-type="pmid">26041797</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vibholm</surname><given-names>LK</given-names></name><name><surname>Nielsen</surname><given-names>SSF</given-names></name><name><surname>Pahus</surname><given-names>MH</given-names></name><name><surname>Frattari</surname><given-names>GS</given-names></name><name><surname>Olesen</surname><given-names>R</given-names></name><name><surname>Andersen</surname><given-names>R</given-names></name><name><surname>Monrad</surname><given-names>I</given-names></name><name><surname>Andersen</surname><given-names>AHF</given-names></name><name><surname>Thomsen</surname><given-names>MM</given-names></name><name><surname>Konrad</surname><given-names>CV</given-names></name><name><surname>Andersen</surname><given-names>SD</given-names></name><name><surname>Højen</surname><given-names>JF</given-names></name><name><surname>Gunst</surname><given-names>JD</given-names></name><name><surname>Østergaard</surname><given-names>L</given-names></name><name><surname>Søgaard</surname><given-names>OS</given-names></name><name><surname>Schleimann</surname><given-names>MH</given-names></name><name><surname>Tolstrup</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>SARS-Cov-2 persistence is associated with antigen-specific Cd8 T-cell responses</article-title><source>EBioMedicine</source><volume>64</volume><elocation-id>103230</elocation-id><pub-id pub-id-type="doi">10.1016/j.ebiom.2021.103230</pub-id><pub-id pub-id-type="pmid">33530000</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Visvabharathy</surname><given-names>L</given-names></name><name><surname>Hanson</surname><given-names>B</given-names></name><name><surname>Orban</surname><given-names>Z</given-names></name><name><surname>Lim</surname><given-names>PH</given-names></name><name><surname>Palacio</surname><given-names>NM</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Clark</surname><given-names>JR</given-names></name><name><surname>Graham</surname><given-names>EL</given-names></name><name><surname>Liotta</surname><given-names>EM</given-names></name><name><surname>Penaloza-MacMaster</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Neuro-COVID long-haulers exhibit broad dysfunction in T cell memory generation and responses to vaccination</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2021.08.08.21261763</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisberg</surname><given-names>SP</given-names></name><name><surname>Ural</surname><given-names>BB</given-names></name><name><surname>Farber</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Tissue-specific immunity for a changing world</article-title><source>Cell</source><volume>184</volume><fpage>1517</fpage><lpage>1529</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.01.042</pub-id><pub-id pub-id-type="pmid">33740452</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>HW</given-names></name><name><surname>Amo-Addae</surname><given-names>M</given-names></name><name><surname>Kenu</surname><given-names>E</given-names></name><name><surname>Ilesanmi</surname><given-names>OS</given-names></name><name><surname>Ameme</surname><given-names>DK</given-names></name><name><surname>Sackey</surname><given-names>SO</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Post-Ebola syndrome among Ebola virus disease survivors in Montserrado County, Liberia 2016</article-title><source>BioMed Research International</source><volume>2018</volume><elocation-id>1909410</elocation-id><pub-id pub-id-type="doi">10.1155/2018/1909410</pub-id><pub-id pub-id-type="pmid">30050920</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wölfel</surname><given-names>R</given-names></name><name><surname>Corman</surname><given-names>VM</given-names></name><name><surname>Guggemos</surname><given-names>W</given-names></name><name><surname>Seilmaier</surname><given-names>M</given-names></name><name><surname>Zange</surname><given-names>S</given-names></name><name><surname>Müller</surname><given-names>MA</given-names></name><name><surname>Niemeyer</surname><given-names>D</given-names></name><name><surname>Jones</surname><given-names>TC</given-names></name><name><surname>Vollmar</surname><given-names>P</given-names></name><name><surname>Rothe</surname><given-names>C</given-names></name><name><surname>Hoelscher</surname><given-names>M</given-names></name><name><surname>Bleicker</surname><given-names>T</given-names></name><name><surname>Brünink</surname><given-names>S</given-names></name><name><surname>Schneider</surname><given-names>J</given-names></name><name><surname>Ehmann</surname><given-names>R</given-names></name><name><surname>Zwirglmaier</surname><given-names>K</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>Wendtner</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Virological assessment of hospitalized patients with COVID-2019</article-title><source>Nature</source><volume>588</volume><fpage>465</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2984-3</pub-id><pub-id pub-id-type="pmid">33303961</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Co-reactivation of the human Herpesvirus alpha Subfamily (herpes Simplex Virus-1 and Varicella Zoster virus) in a critically ill patient with COVID-19</article-title><source>The British Journal of Dermatology</source><volume>183</volume><fpage>1145</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.1111/bjd.19484</pub-id><pub-id pub-id-type="pmid">32790074</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamayoshi</surname><given-names>S</given-names></name><name><surname>Yasuhara</surname><given-names>A</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Akasaka</surname><given-names>O</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Nakachi</surname><given-names>I</given-names></name><name><surname>Koga</surname><given-names>M</given-names></name><name><surname>Mitamura</surname><given-names>K</given-names></name><name><surname>Yagi</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Nojima</surname><given-names>M</given-names></name><name><surname>Pattinson</surname><given-names>D</given-names></name><name><surname>Ogura</surname><given-names>T</given-names></name><name><surname>Baba</surname><given-names>R</given-names></name><name><surname>Fujita</surname><given-names>K</given-names></name><name><surname>Nagai</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Adachi</surname><given-names>E</given-names></name><name><surname>Ochi</surname><given-names>J</given-names></name><name><surname>Hattori</surname><given-names>S-I</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Miyazato</surname><given-names>Y</given-names></name><name><surname>Chiba</surname><given-names>S</given-names></name><name><surname>Okuda</surname><given-names>M</given-names></name><name><surname>Murakami</surname><given-names>J</given-names></name><name><surname>Hamabata</surname><given-names>T</given-names></name><name><surname>Iwatsuki-Horimoto</surname><given-names>K</given-names></name><name><surname>Nakajima</surname><given-names>H</given-names></name><name><surname>Mitsuya</surname><given-names>H</given-names></name><name><surname>Omagari</surname><given-names>N</given-names></name><name><surname>Sugaya</surname><given-names>N</given-names></name><name><surname>Yotsuyanagi</surname><given-names>H</given-names></name><name><surname>Kawaoka</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Antibody titers against SARS-Cov-2 decline, but do not disappear for several months</article-title><source>EClinicalMedicine</source><volume>32</volume><elocation-id>100734</elocation-id><pub-id pub-id-type="doi">10.1016/j.eclinm.2021.100734</pub-id><pub-id pub-id-type="pmid">33589882</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structural basis for the recognition of SARS-Cov-2 by full-length human Ace2</article-title><source>Science</source><volume>367</volume><fpage>1444</fpage><lpage>1448</lpage><pub-id pub-id-type="doi">10.1126/science.abb2762</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>AC</given-names></name><name><surname>Kern</surname><given-names>F</given-names></name><name><surname>Losada</surname><given-names>PM</given-names></name><name><surname>Agam</surname><given-names>MR</given-names></name><name><surname>Maat</surname><given-names>CA</given-names></name><name><surname>Schmartz</surname><given-names>GP</given-names></name><name><surname>Fehlmann</surname><given-names>T</given-names></name><name><surname>Stein</surname><given-names>JA</given-names></name><name><surname>Schaum</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>DP</given-names></name><name><surname>Calcuttawala</surname><given-names>K</given-names></name><name><surname>Vest</surname><given-names>RT</given-names></name><name><surname>Berdnik</surname><given-names>D</given-names></name><name><surname>Lu</surname><given-names>N</given-names></name><name><surname>Hahn</surname><given-names>O</given-names></name><name><surname>Gate</surname><given-names>D</given-names></name><name><surname>McNerney</surname><given-names>MW</given-names></name><name><surname>Channappa</surname><given-names>D</given-names></name><name><surname>Cobos</surname><given-names>I</given-names></name><name><surname>Ludwig</surname><given-names>N</given-names></name><name><surname>Schulz-Schaeffer</surname><given-names>WJ</given-names></name><name><surname>Keller</surname><given-names>A</given-names></name><name><surname>Wyss-Coray</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Publisher correction: dysregulation of brain and choroid plexus cell types in severe COVID-19</article-title><source>Nature</source><volume>598</volume><elocation-id>E4</elocation-id><pub-id pub-id-type="doi">10.1038/s41586-021-04080-3</pub-id><pub-id pub-id-type="pmid">34625744</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaid</surname><given-names>A</given-names></name><name><surname>Gérardin</surname><given-names>P</given-names></name><name><surname>Taylor</surname><given-names>A</given-names></name><name><surname>Mostafavi</surname><given-names>H</given-names></name><name><surname>Malvy</surname><given-names>D</given-names></name><name><surname>Mahalingam</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Chikungunya arthritis: Implications of acute and chronic inflammation mechanisms on disease management</article-title><source>Arthritis &amp; Rheumatology</source><volume>70</volume><fpage>484</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1002/art.40403</pub-id><pub-id pub-id-type="pmid">29287308</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Song</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Functional exhaustion of antiviral lymphocytes in COVID-19 patients</article-title><source>Cellular &amp; Molecular Immunology</source><volume>17</volume><fpage>533</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1038/s41423-020-0402-2</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zollner</surname><given-names>A</given-names></name><name><surname>Koch</surname><given-names>R</given-names></name><name><surname>Jukic</surname><given-names>A</given-names></name><name><surname>Pfister</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>M</given-names></name><name><surname>Rössler</surname><given-names>A</given-names></name><name><surname>Kimpel</surname><given-names>J</given-names></name><name><surname>Adolph</surname><given-names>TE</given-names></name><name><surname>Tilg</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases</article-title><source>Gastroenterology</source><volume>163</volume><fpage>495</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2022.04.037</pub-id><pub-id pub-id-type="pmid">35508284</pub-id></element-citation></ref></ref-list></back></article>